<!DOCTYPE article
 PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.2 20190208//EN" "JATS-archivearticle1.dtd">
<article xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" article-type="preprint"><?all-math-mml yes?><?use-mml?><?origin ukpmcpa?><front><journal-meta><journal-id journal-id-type="nlm-ta">bioRxiv</journal-id><journal-title-group><journal-title>bioRxiv : the preprint server for biology</journal-title></journal-title-group><issn pub-type="ppub"/></journal-meta><article-meta><article-id pub-id-type="manuscript">EMS189900</article-id><article-id pub-id-type="doi">10.1101/2023.10.18.562909</article-id><article-id pub-id-type="archive">PPR744763</article-id><article-version-alternatives><article-version article-version-type="status">preprint</article-version><article-version article-version-type="number">1</article-version></article-version-alternatives><article-categories><subj-group subj-group-type="heading"><subject>Article</subject></subj-group></article-categories><title-group><article-title>Bacterial surface lipoproteins mediate epithelial microinvasion by <italic>Streptococcus pneumoniae</italic></article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Chan</surname><given-names>Jia Mun</given-names></name><xref ref-type="aff" rid="A1">a</xref><xref ref-type="corresp" rid="CR1">#</xref></contrib><contrib contrib-type="author"><name><surname>Ramos-Sevillano</surname><given-names>Elisa</given-names></name><xref ref-type="aff" rid="A2">b</xref></contrib><contrib contrib-type="author"><name><surname>Betts</surname><given-names>Modupeh</given-names></name><xref ref-type="aff" rid="A1">a</xref><xref ref-type="fn" rid="FN1">*</xref></contrib><contrib contrib-type="author"><name><surname>Wilson</surname><given-names>Holly U.</given-names></name><xref ref-type="aff" rid="A1">a</xref></contrib><contrib contrib-type="author"><name><surname>Weight</surname><given-names>Caroline M.</given-names></name><xref ref-type="aff" rid="A1">a</xref><xref ref-type="fn" rid="FN1">**</xref></contrib><contrib contrib-type="author"><name><surname>Houhou-Ousalah</surname><given-names>Ambrine</given-names></name><xref ref-type="aff" rid="A1">a</xref></contrib><contrib contrib-type="author"><name><surname>Pollara</surname><given-names>Gabriele</given-names></name><xref ref-type="aff" rid="A1">a</xref></contrib><contrib contrib-type="author"><name><surname>Brown</surname><given-names>Jeremy S.</given-names></name><xref ref-type="aff" rid="A2">b</xref></contrib><contrib contrib-type="author"><name><surname>Heyderman</surname><given-names>Robert S.</given-names></name><xref ref-type="aff" rid="A1">a</xref><xref ref-type="corresp" rid="CR1">#</xref></contrib></contrib-group><aff id="A1"><label>a</label>Research Department of Infection, Division of Infection and Immunity, University College London, London, UK</aff><aff id="A2"><label>b</label>Department of Respiratory Medicine, Centre for Inflammation and Tissue Repair, University College London, London, United Kingdom</aff><author-notes><corresp id="CR1"><label>*</label>Address correspondence to Jia Mun (Elizabeth) Chan, <email>elizabeth.jm.chan@ucl.ac.uk</email> or Robert S. Heyderman, <email>r.heyderman@ucl.ac.uk</email>.</corresp><fn id="FN1" fn-type="present-address"><label>*</label><p id="P1">Present address: Institute of Infection, Veterinary and Ecological Sciences, University of Liverpool, Liverpool, UK.</p></fn><fn id="FN2" fn-type="present-address"><label>**</label><p id="P2">Present address: Department of Biomedical and Life Sciences, Lancaster University, Lancaster, UK.</p></fn></author-notes><pub-date pub-type="nihms-submitted"><day>21</day><month>10</month><year>2023</year></pub-date><pub-date pub-type="preprint"><day>19</day><month>10</month><year>2023</year></pub-date><permissions><ali:free_to_read/><license><ali:license_ref>https://creativecommons.org/licenses/by-nc-nd/4.0/</ali:license_ref><license-p>This work is licensed under a <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">CC BY-NC-ND 4.0 International license</ext-link>.</license-p></license></permissions><abstract><p id="P3"><italic>Streptococcus pneumoniae,</italic> a common coloniser of the upper respiratory tract, invades nasopharyngeal epithelial cells without causing disease in healthy people. We hypothesised that surface expression of pneumococcal lipoproteins, recognised by the innate immune receptor TLR2, mediate epithelial microinvasion. Mutation of <italic>lgt</italic> in serotype 4 (TIGR4) and serotype 6B (BHN418) pneumococcal strains abolishes the ability of the mutants to activate TLR2 signalling. Loss of <italic>lgt</italic> also led to concomitant decrease in interferon signalling triggered by the bacterium. However, only BHN418 <italic>lgt::cm</italic> but not TIGR4 <italic>lgt::cm</italic> was significantly attenuated in epithelial adherence and microinvasion compared to their respective wild-type strains. To test the hypothesis that differential lipoprotein repertoires in TIGR4 and BHN418 lead to the intraspecies variation in epithelial microinvasion, we employed a motif-based genome analysis and identified an additional 525 a.a. lipoprotein (pneumococcal accessory lipoprotein A; <italic>palA)</italic> encoded by BHN418 that is absent in TIGR4. The gene encoding <italic>palA</italic> sits within a putative genetic island present in ~10% of global pneumococcal isolates. While <italic>palA</italic> was enriched in carriage and otitis media pneumococcal strains, neither mutation nor overexpression of the gene encoding this lipoprotein significantly changed microinvasion patterns. In conclusion, mutation of <italic>lgt</italic> attenuates epithelial inflammatory responses during pneumococcal-epithelial interactions, with intraspecies variation in the effect on microinvasion. Differential lipoprotein repertoires encoded by the different strains do not explain these differences in microinvasion. Rather, we postulate that post-translational modifications of lipoproteins may account for the differences in microinvasion.</p></abstract><kwd-group><kwd><italic>Streptococcus pneumoniae</italic></kwd><kwd>host-microbe interactions</kwd><kwd>microinvasion</kwd><kwd>bacterial lipoproteins</kwd><kwd>epithelium</kwd></kwd-group></article-meta></front><body><sec id="S1" sec-type="intro"><title>Introduction</title><p id="P4"><italic>Streptococcus pneumoniae</italic> (pneumococcus) is a versatile pathobiont capable of asymptomatically colonising the nasopharynx, causing localised infections of the middle ear, respiratory tract and lungs, and causing disseminated invasive disease (e.g. bacteraemic pneumonia and meningitis) with high mortality rates (<xref ref-type="bibr" rid="R1">1</xref>). <italic>S. pneumoniae</italic> has long been considered an extracellular pathogen despite demonstration of bacterial invasion <italic>in vitro</italic> using epithelial and endothelial cell lines (<xref ref-type="bibr" rid="R1">1</xref>). However, controlled human infection with a serotype 6B strain revealed that the pneumococcus invades the nasopharyngeal epithelium of healthy carriers, stimulating epithelial inflammation without causing overt symptoms or disease (<xref ref-type="bibr" rid="R2">2</xref>–<xref ref-type="bibr" rid="R4">4</xref>). We have termed this phenomenon microinvasion, which is distinct from the invasion of deeper tissues or dissemination systemically which characterise disease (<xref ref-type="bibr" rid="R2">2</xref>). Inflammation triggered by the epithelium-associated and intracellular bacteria, which peaks 9 days post inoculation, may be important for clearance and onward transmission (<xref ref-type="bibr" rid="R2">2</xref>).</p><p id="P5">In this study, we explored the hypothesis that surface expression of pneumococcal lipoproteins mediate epithelial microinvasion. Pneumococcal lipoproteins are post-translationally lipidated surface proteins, many of which function as metabolite transporters (<xref ref-type="bibr" rid="R5">5</xref>, <xref ref-type="bibr" rid="R6">6</xref>). <italic>S. pneumoniae</italic> lipoproteins have also been shown to be major TLR2 ligands in macrophages, are required for a Th17 response and for many of the dominant macrophage gene transcriptional responses, such as induction of IRAK-4–dependent protective cytokines (<xref ref-type="bibr" rid="R7">7</xref>–<xref ref-type="bibr" rid="R9">9</xref>). <italic>S. pneumoniae</italic> encodes over 30 lipoproteins, including the bifunctional adhesin/manganese transporter PsaA and the peptidoglycan hydrolase DacB (<xref ref-type="bibr" rid="R5">5</xref>, <xref ref-type="bibr" rid="R10">10</xref>–<xref ref-type="bibr" rid="R12">12</xref>). Blocking lipidation by mutating the prolipoprotein diacylglyceryl transferase encoding gene <italic>lgt</italic> de-anchors lipoproteins from the cell surface, resulting in the release of immature preprolipoproteins into the extracellular milieu and abolishing the ability of the bacteria to activate TLR2 signalling (<xref ref-type="bibr" rid="R8">8</xref>, <xref ref-type="bibr" rid="R9">9</xref>, <xref ref-type="bibr" rid="R13">13</xref>). Mutating <italic>lgt</italic> also attenuates pneumococcal virulence and shortens colonisation duration in murine models (<xref ref-type="bibr" rid="R8">8</xref>, <xref ref-type="bibr" rid="R14">14</xref>).</p><p id="P6">To explore whether heterogeneity in surface-expression of pneumococcal lipoproteins also explains the differences in microinvasion seen between strains, we blocked lipoprotein lipidation by inactivation of <italic>lgt</italic> in two strains: a highly invasive strain (TIGR4, serotype 4) and a less invasive strain (BHN418, serotype 6B) which was used in the controlled human challenge experiments (<xref ref-type="bibr" rid="R15">15</xref>, <xref ref-type="bibr" rid="R16">16</xref>). It is important to note that pneumococcal strains from both serotypes can asymptomatically colonise as well as cause invasive disease in susceptible hosts, albeit to different extents (<xref ref-type="bibr" rid="R17">17</xref>). Our findings indicate that lipoproteins contributed to epithelial inflammation by activating the TLR2 pathway and augmenting an interferon response. While attenuation of inflammatory responses were seen with both serotype 6B and serotype 4 <italic>lgt</italic> mutants, we observed intraspecies differences in the contribution of lipoproteins to microinvasion, with greater effects of lipoproteins with the less invasive 6B strain.</p><p id="P7">Genomic analysis revealed the presence of a previously uncharacterised lipoprotein encoded within a genetic island found in BHN418 and approximately 10% of pneumococcal strains, but not in TIGR4. We designate this protein pneumocccal accessory lipoprotein A, or PalA. We hypothesized <italic>that palA</italic> mediate the intraspecies differences in microinvasion, however, cell culture and murine colonisation experiments did not show an essential role for <italic>palA</italic> in microinvasion, colonisation or disease. Our results suggest that the contribution of lipoproteins and lipoprotein processing to microinvasion may be more complex and we propose may occur through differential post-translational lipidation.</p></sec><sec id="S2" sec-type="results"><title>Results</title><sec id="S3"><title>Pneumococcal <italic>lgt</italic> mutants induce lower levels of TLR2 and interferon signalling compared to than wild type strains</title><p id="P8">In line with previous reports, mutation of <italic>lgt</italic> in both TIGR4 and BHN418 completely abolished the ability of these strains to trigger TLR2 signalling in HEK-Blue™ hTLR2 reporter cells, while genetic complementation of <italic>lgt</italic> at a chromosomal ectopic site restored WT-like ability to stimulate the TLR2 pathway (<xref ref-type="fig" rid="F1">Figure 1A</xref>) (<xref ref-type="bibr" rid="R9">9</xref>). Although macrophages respond to pneumococcal infections by activating TLR2 signalling pathways, it is unknown if nasopharyngeal epithelial cells respond in the same way (<xref ref-type="bibr" rid="R8">8</xref>, <xref ref-type="bibr" rid="R9">9</xref>, <xref ref-type="bibr" rid="R18">18</xref>). Using a transcriptional module reflective of TLR2 signalling and previously published transcriptomic datasets (<xref ref-type="bibr" rid="R2">2</xref>, <xref ref-type="bibr" rid="R19">19</xref>), we found evidence of elevated TLR2-mediated transcriptional activity in nasopharyngeal epithelial cells infected with TIGR4 and BHN418 (<xref ref-type="fig" rid="F1">Figure 1B</xref>; <xref ref-type="supplementary-material" rid="SD1">Supplementary Figure 1</xref>).</p><p id="P9">TLR2 activation is necessary for full induction of TLR4 by the <italic>S. pneumoniae</italic> virulence factor pneumolysin (<xref ref-type="bibr" rid="R20">20</xref>, <xref ref-type="bibr" rid="R21">21</xref>). Transcriptomic analyses of human nasal biopsy samples from controlled pneumococcal challenge experiments and nasopharyngeal cell lines infected with <italic>S. pneumoniae</italic> also showed upregulation of interferon signalling (<xref ref-type="bibr" rid="R6">6</xref>, <xref ref-type="bibr" rid="R7">7</xref>). We therefore hypothesize that TLR2 activation potentiates interferon signalling in epithelial cells triggered by <italic>S. pneumoniae</italic> infection. Using qPCR, we observed that Detroit 562 cells infected with TIGR4 <italic>lgt::cm</italic> have reduced expression of <italic>CXCL10, IFNB1</italic> and <italic>IFNL1</italic> compared to cells infected with WT TIGR4 (<xref ref-type="fig" rid="F1">Figure 1C-E</xref>), while cells infected with BHN418 <italic>lgt::cm</italic> have reduced expression of <italic>CXCL10</italic> and <italic>IFNL3</italic> compared to those infected with WT BHN418 (<xref ref-type="fig" rid="F1">Figure 1C,1F</xref>).</p><p id="P10">Our results suggest that lipoprotein-mediated TLR2 activation augments the epithelial interferon response during pneumococcal microinvasion.</p></sec><sec id="S4"><title>Mutation of <italic>lgt</italic> attenuates epithelial microinvasion by <italic>S. pneumoniae</italic> serotype 6B but not by serotype 4</title><p id="P11">To determine if mutation of <italic>lgt</italic> and loss of TLR2 signalling impact on pneumococcal microinvasion, we infected confluent Detroit 562 nasopharyngeal cells (NPE) with the serotype 6B (BHN418) and 4 strains (TIGR4) for 3 hours (3 hpi), measuring the number of cell associated, intracellular and planktonic bacteria in the cell culture supernatant. Mutation of <italic>lgt</italic> significantly attenuated the ability of BHN418 but not TIGR4 to associate with and be internalised into Detroit 562 cells (<xref ref-type="fig" rid="F2">Figure 2A-B, 2D-2E</xref>). In concordance with prior reports, serotype 4 strains were more invasive compared to serotype 6B strains, with ~5 times more intracellular WT TIGR4 recovered compared to WT BHN418 (<xref ref-type="fig" rid="F2">Figure 2B, 2D</xref>) (<xref ref-type="bibr" rid="R15">15</xref>, <xref ref-type="bibr" rid="R17">17</xref>). The <italic>lgt</italic> mutation also significantly reduced the number of planktonic BHN418 but not TIGR4 (<xref ref-type="fig" rid="F2">Figure 2F</xref>). Genetic complementation of <italic>lgt</italic> in the BHN418 <italic>lgt::cm</italic> mutant did not fully restore microinvasion of NPE cells to WT-like levels, despite complementation in the HEK-Blue™ hTLR2 reporter assay (<xref ref-type="fig" rid="F1">Figure 1A</xref>, <xref ref-type="fig" rid="F2">Figure 2A-F</xref>).</p><p id="P12">Mutation of <italic>lgt</italic> has been associated with growth defects in cation-limiting conditions, human blood and mouse bronchoalveolar lavage fluid (<xref ref-type="bibr" rid="R14">14</xref>). Fewer planktonic BHN418 <italic>lgt</italic> mutant bacteria were also recovered from our NPE infection experiments (<xref ref-type="fig" rid="F2">Figure 2C</xref>). Time course sampling of planktonic pneumococci grown with Detroit 562 cells revealed a minor growth defect for the BHN418 <italic>lgt</italic> mutant starting at 3 hpi but not for the TIGR4 <italic>lgt</italic> mutant (<xref ref-type="fig" rid="F3">Figure 3A-B</xref>). To determine if the growth defect was dependent on the presence of NPE cells, time course sampling of planktonic BHN418 and its <italic>lgt</italic> mutant grown in infection medium and rich THY medium were performed. The growth defect was replicated in cell-free medium and is therefore not dependent on the presence of NPE cells (<xref ref-type="fig" rid="F3">Figure 3C-D</xref>).</p><p id="P13">Our results indicate that inactivation of Lgt and therefore the lipoprotein processing pathway had greater consequences for BHN418 compared to TIGR4, except in their ability to trigger epithelial inflammation. These observations suggest that activation of the TLR2 pathway during pneumococcal-epithelial interactions is not dependent on the number of cell-associated or intracellular pneumococci. Additionally, within the timeframe of our assays, TLR2 signalling neither promotes nor inhibits epithelial microinvasion by <italic>S. pneumoniae</italic>.</p></sec><sec id="S5"><title>BHN418 encodes a novel lipoprotein absent in TIGR4</title><p id="P14">One potential explanation for the intraspecies differences in microinvasion upon <italic>lgt</italic> mutation is the presence of one or more lipoproteins in BHN418 which are absent in TIGR4. This lipoprotein may play a role as an adhesin and/or be important for nutrient transport and growth during infections. To address this hypothesis, we used a motif-based sequence toolkit, the MEME Suite, to compare the lipoprotein repertoires of BHN418 and TIGR4 (<xref ref-type="bibr" rid="R22">22</xref>). We identified 43 open reading frames (ORFs) in TIGR4 and 44 ORFs in BHN418 with gene products that fit the criteria for a lipoprotein (detailed in Materials and Methods) (<xref ref-type="table" rid="T1">Table 1</xref>). Of these putative lipoprotein ORFs, only one is present in BHN418 but not in TIGR4. There are no lipoprotein ORFs present in TIGR4 that are not also present in BHN418.</p><p id="P15">The lipoprotein encoded by BHN418 but not TIGR4, encoded by the gene with the locus tag RSS80_03595 and which we named pneumococcal accesssory lipoprotein A (PalA), comprises of 525 amino acids with sequence and structural homology to extracellular solute binding domain proteins that deliver substrates to ABC family transporters (<xref ref-type="fig" rid="F4">Figure 4A-B</xref>). ABC transporters are multi subunit proteins comprising of two transmembrane permease domains and two cytoplasmic ATPase domains (<xref ref-type="bibr" rid="R23">23</xref>). Two genes encoding ABC transporter permease domain proteins, annotated as <italic>yteP</italic> and <italic>araQ,</italic> were found ~3.3kb and ~2.4kb upstream of <italic>palA.</italic> We were unable to locate ORF(s) encoding for the ATPase domain proteins in the 10kb region upstream or downstream of <italic>palA.</italic> Taken together, PalA likely binds to and delivers substrate(s) to YteP and/or AraQ. It is uncertain if YteP and/or AraQ co-opt the ATPase domains of ABC family transporters encoded elsewhere on the genome, in a similar strategy as the raffinose utilisation system, or no longer function as transporters (<xref ref-type="bibr" rid="R24">24</xref>, <xref ref-type="bibr" rid="R25">25</xref>).</p><p id="P16">This genetic context suggests that <italic>palA</italic> is the fifth gene in an operon encoding for carbohydrate import and utilisation genes, which includes <italic>yteP</italic> and <italic>araQ</italic> (<xref ref-type="fig" rid="F4">Figure 4A</xref>). The operon sits within an 11.5 kb region with ~30% GC content, flanked by repetitive insertion sequences with homology to <italic>IS630</italic> elements. This region was likely acquired via horizontal gene transfer as the overall mean GC content of pneumococcal strains is around 40% (<xref ref-type="bibr" rid="R26">26</xref>). This putative genetic island is directly downstream of <italic>spxB,</italic> which encodes an important pneumococcal virulence factor involved in the production of H<sub>2</sub>O<sub>2</sub> (<xref ref-type="bibr" rid="R27">27</xref>). Alignment of TIGR4 whole genome sequencing reads to the BHN418 genome revealed the absence of the entire putative island in the TIGR4 genome (<xref ref-type="fig" rid="F4">Figure 4C</xref>) (<xref ref-type="bibr" rid="R26">26</xref>).</p><p id="P17">To determine if <italic>palA</italic> is predominantly present in more carriage-type serotypes, such as serotype 6B, we examined the presence of <italic>palA</italic> in a well-curated dataset of 2806 carriage isolates from Malawi (<xref ref-type="bibr" rid="R48">48</xref>). 567 of these carriage isolates (20.5%) carry <italic>palA</italic> in their chromosome. Mapping the analysis results onto a hierarchal clustering (Newick) tree showed that <italic>palA</italic> is present in specific lineages, with no clear association to capsular serotypes or sequence types (genetic relatedness, visualised as neighbouring branches on a Newick tree) (<xref ref-type="supplementary-material" rid="SD1">Supplementary Figure 2</xref>) (<xref ref-type="bibr" rid="R48">48</xref>). However, presence of <italic>palA</italic> is enriched in certain serotypes, particularly serotype 6A (39/93, 41.9%), 6B (12/31,38.7%), 10A (29/34, 85%), 15B (52.76, 68.4%), 16F (60/94, 63.8%), 23B (45/103, 43.7%), 35A (28/28, 100%) and 35B (60/114, 52.6%) (<xref ref-type="supplementary-material" rid="SD1">Supplementary Table 1</xref>). Additionally, the branching patterns of the phylogenetic tree for the Malawi carriage isolates supports the inference that <italic>palA</italic> and its associated genetic island were acquired via horizontal gene transfer and expanded in specific lineages (<xref ref-type="supplementary-material" rid="SD1">Supplementary Figure 2</xref>).</p></sec><sec id="S6"><title>PalA presence is enriched in carriage and ear isolates</title><p id="P18">Maintenance of this 11.5kb genetic island is potentially costly and suggests that the island confers some form of advantage to isolates that carry it. <italic>S. pneumoniae</italic> is capable of colonising and infecting multiple body sites including the nasopharynx, lungs, blood, CSF, meninges, and middle ear. We therefore examined 51,379 genomes in the BIGSdb database to determine if there is an association between the presence of <italic>palA</italic> and the isolation site of the strain (“source”) (<xref ref-type="bibr" rid="R49">49</xref>).</p><p id="P19">The <italic>palA</italic> gene presence is enriched in carriage isolates and in strains isolated from ear infections compared to strains isolated from IPD or lower respiratory tract disease (<xref ref-type="table" rid="T2">Table 2</xref>). More than half of serotype 22F and 6A strains isolated from the ear carried <italic>palA</italic> and approximately 28% of all serotype 22F and 6A genomes in the database carry <italic>palA,</italic> in contrast to the overall <italic>palA</italic> prevalence rate of 9.97% (<xref ref-type="table" rid="T2">Table 2</xref>). In the BIGSdb database, the only serotype 4 strain isolated from the ear carried <italic>palA</italic> in its genome. These observations suggest that <italic>palA</italic> and/or its putative genetic island may facilitate spread to and cause infection of the ear, although <italic>palA’s</italic> presence is not necessary for colonisation of the ear.</p></sec><sec id="S7"><title>Mutation of <italic>palA</italic> does not alter pneumococcal colonisation or microinvasion of the epithelium</title><p id="P20">To determine if PalA plays a role in epithelial microinvasion, we generated <italic>palA</italic> deletion and complementation mutants for testing in our NPE model. Although there is a small reduction in the number of planktonic bacteria, the numbers of epithelial-associated and intracellular BHN418 <italic>palA::kan</italic> were not significantly different to that of WT BHN418 (<xref ref-type="fig" rid="F5">Figure 5A-C</xref>). Additionally, we did not observe a growth defect when BHN418 <italic>palA::kan</italic> was grown in THY or MEM (<xref ref-type="fig" rid="F5">Figure 5D-E</xref>).</p><p id="P21">Heterologous expression of <italic>palA</italic> in a serotype 23F strain naturally lacking the island (P1121) did not increase the microinvasion potential of the resulting strains and reduced the number of planktonic bacteria in the cell culture supernatant (<xref ref-type="fig" rid="F6">Figure 6A-C</xref>). Moreover, the BHN418 <italic>palA</italic> knockout strains and the P1121 <italic>palA</italic> knock-in strains activated TLR2 signalling to similar levels as their respective wild-type strains (<xref ref-type="fig" rid="F6">Figure 6D</xref>). We therefore conclude that presence of <italic>palA</italic> is not solely responsible for the observed strain-specific differences in Lgt-mediated epithelial microinvasion. Moreover, PalA does not contribute significantly to pneumococci’s ability to activate TLR2.</p><p id="P22">Mutation of <italic>palA</italic> attenuates nasopharyngeal colonisation density and duration in mice (<xref ref-type="bibr" rid="R14">14</xref>). We next asked if presence of <italic>palA</italic> confer a survival advantage in a more complex and immune-replete environment such as the murine nasopharynx. Outbred CD-1 female mice were intranasally inoculated with wild-type BHN418 and the <italic>palA</italic> mutant either singly or in a 1:1 competitive mix. After 7 days of colonisation, similar CFU numbers for WT BHN418 and the <italic>palA::kan</italic> were recovered from nasal washes (<xref ref-type="fig" rid="F5">Figure 5F-G</xref>). Similar CFU numbers for BHN418 and <italic>palA::kan</italic> were also recovered in homogenised lungs and blood 24 hours post inoculation in a murine pneumonia model (<xref ref-type="fig" rid="F5">Figure 5H-I</xref>). We conclude that presence of <italic>palA</italic> does not confer a colonisation advantage in the murine nasopharynx or in the progression to bacteraemic pneumonia.</p></sec></sec><sec id="S8" sec-type="discussion"><title>Discussion</title><p id="P23">In this study, we demonstrated that pneumococcal lipoproteins trigger inflammation during epithelial colonisation at least partially via the TLR2-dependent pathway. We have previously shown that epithelial microinvasion occurs in the absence of disease and that there is heightened epithelial inflammation around the time of pneumococcal clearance in controlled human infection (<xref ref-type="bibr" rid="R2">2</xref>). In murine models, mutation of <italic>lgt</italic> reduces carriage duration and attenuates disease, associated with a concomitant reduction in inflammatory and immune responses (<xref ref-type="bibr" rid="R8">8</xref>, <xref ref-type="bibr" rid="R9">9</xref>, <xref ref-type="bibr" rid="R50">50</xref>). However, although we have shown that BHN418 <italic>lgt::cm</italic> but not TIGR4 <italic>lgt::cm</italic> was significantly attenuated in epithelial adherence and microinvasion compared to their respective wild-type strains, this does not appear to be TLR2-dependent or due to differential lipoprotein repertoires encoded by the strains.</p><p id="P24">We additionally observed that presence of <italic>lgt</italic> and therefore TLR2 activation heightens the epithelial interferon response elicited by pneumococcal microinvasion in the absence of immune cells. Induction of the interferon pathway upon pneumococcal challenge is thought to be dependent on sensing of intracellular pneumococci, pneumococcal DNA or cellular DNA damage by the infected cells (<xref ref-type="bibr" rid="R51">51</xref>–<xref ref-type="bibr" rid="R56">56</xref>). In infant mice co-infected with pneumococci and influenzae, interferon signalling increases bacterial shedding while protecting against invasive disease, while TLR2 signalling limits bacterial shedding and transmission (<xref ref-type="bibr" rid="R18">18</xref>, <xref ref-type="bibr" rid="R57">57</xref>, <xref ref-type="bibr" rid="R58">58</xref>). Since TLR2 signalling augments the interferon response by human nasopharyngeal epithelial cells during mono-pneumococcal infection, it is unclear how these two pathways mediate the outcomes of pneumococcal microinvasion, colonisation or progression to disease in people. Nonetheless, our results suggest that mucosal innate immunity could be targeted alongside the induction of an adaptive immune response to prevent pneumococcal colonisation, transmission and invasive disease.</p><p id="P25">We have implicated lipoprotein expression in intraspecies differences in NPE cell microinvasion but our genetic and mutational analysis lead us to suggest that this is not due to differences in lipoprotein repertoire, but rather due to differential post-translational lipidation. The lipoprotein PsaA functions as a bacterial adhesin which binds to host cell E-cadherin (<xref ref-type="bibr" rid="R59">59</xref>). In theory, we should have observed a significant reduction in the number of epithelial-associated bacteria for both the TIGR4 and BHN418 <italic>lgt</italic> mutants compared to wild-type due to the loss of PsaA surface presentation; however, our data did not reflect this hypothesis. Similar subtle effects have been seen for example when mutating the lipoprotein encoding gene <italic>dacB</italic> but not <italic>lgt</italic> alters murein sacculus composition, and when mutating <italic>lgt</italic> results in strain-dependent variable effects on growth in rich medium (<xref ref-type="bibr" rid="R5">5</xref>, <xref ref-type="bibr" rid="R9">9</xref>, <xref ref-type="bibr" rid="R14">14</xref>, <xref ref-type="bibr" rid="R50">50</xref>, <xref ref-type="bibr" rid="R60">60</xref>). The observation that genetic complementation of <italic>lgt</italic> in BHN418 restores pneumococcal ability to trigger epithelial inflammation but not WT levels of microinvasion further suggests that regulation of lipoprotein processing may be more complex than previously thought. The assumption that Lgt and other lipoprotein modification proteins are constitutively expressed and active, and all 30+ lipoproteins are processed at similar rates may not be entirely correct. Proteomics and immunoblotting analyses showed that abundance of specific lipoproteins may increase, decrease or show no change when lipoprotein processing is disrupted in <italic>S. pneumoniae,</italic> although no clear patterns were apparent (<xref ref-type="bibr" rid="R5">5</xref>, <xref ref-type="bibr" rid="R13">13</xref>). We therefore speculate that unlike Gram-negative bacteria, for which lipoprotein processing is essential, pneumococci and other Gram-positive bacteria compensate for the loss of Lgt by differentially regulating expression of lipoprotein encoding genes, which in turn is regulated by external stimuli in nasopharyngeal niche (<xref ref-type="bibr" rid="R61">61</xref>,<xref ref-type="bibr" rid="R62">62</xref>).</p><p id="P26">While investigating the intraspecies variation in the role of <italic>lgt</italic> in microinvasion, we discovered a previously uncharacterised lipoprotein encoding gene <italic>(palA)</italic> and its associated genetic island. Although <italic>palA</italic> presence is enriched in carriage and otitis media isolates, we have not been able to demonstrate a clear role for PalA in epithelial microinvasion, or in a murine model, colonisation or disease. PalA is predicted by sequence and structure homology to be involved in carbohydrate or sugar transport, although we have yet to identify a substrate for PalA. Raffinose metabolism has been shown to contribute to lung versus ear tropism in serotype 3 and serotype 14 strains (<xref ref-type="bibr" rid="R25">25</xref>). It is therefore possible that <italic>palA</italic> functions in promoting niche specialisation by facilitating uptake and metabolism of uncommon sugars, such as raffinose, found in the nasopharynx or middle ear.</p><p id="P27">In conclusion, we demonstrated a role for pneumococcal surface lipoproteins in triggering epithelial inflammation and augmenting interferon signalling in response to pneumococcal-epithelial interactions. We show that pneumococcal lipoproteins mediate microinvasion in a strain-dependent manner, which may explain the significant attenuation in carriage duration and disease with <italic>lgt</italic> mutants reported by others (<xref ref-type="bibr" rid="R8">8</xref>, <xref ref-type="bibr" rid="R14">14</xref>, <xref ref-type="bibr" rid="R50">50</xref>). Additionally, we have characterised a novel accessory lipoprotein likely acquired through horizontal gene transfer but rejected the hypothesis that this lipoprotein contribute to strain differences in pneumococcal epithelial microinvasion. Instead, we postulate that differential regulation of lipoprotein gene expression responding to the nasopharyngeal niche regulate this microinvasion process.</p></sec><sec id="S9" sec-type="materials | methods"><title>Materials and Methods</title><sec id="S10"><title>Bacterial growth and maintenance</title><p id="P28"><italic>Streptococcus pneumoniae</italic> strains were grown on Columbia agar base with 5% defibrinated horse blood (CBA plates; EO Labs, Oxoid) or statically in Todd-Hewitt broth supplemented with 0.5% yeast extract (THY; Oxoid) at 37°C, 5% CO<sup>2</sup>. Where appropriate, growth medium was supplemented with antibiotics at the following concentrations: chloramphenicol (10 μg/ml), erythromycin (0.5 μg/ml), kanamycin (250 μg/ml). Working stocks for infections were prepared by freezing THY cultures at OD<sub>600</sub> 0.3-0.4 with 10% glycerol. NEB® Stable competent <italic>Escherichia coli</italic> derived strains were grown in LB broth or LB agar (Difco) supplemented with ampicillin (200 μg/ml) where appropriate. Bacterial strains used in this paper are listed in <xref ref-type="table" rid="T3">Table 3</xref>.</p></sec><sec id="S11"><title>Bacterial genetic manipulation</title><p id="P29"><italic>S. pneumoniae</italic> were genetically manipulated using a competence stimulating peptide (CSP)-mediated transformation assay (<xref ref-type="bibr" rid="R63">63</xref>). Briefly, pneumococci were grown in THY pH 6.8 supplemented with 1 mM CaCl<sub>2</sub> and 0.02% BSA at 37°C, 5% CO<sub>2</sub> to OD<sub>600</sub> 0.01-0.03, pelleted and resuspended in 1/12 volume THY pH 8.0 supplemented with 1 mM CaCl<sub>2</sub> and 0.2% BSA. A total of 400 ng CSP (Cambridge Biosciences; CSP-2 for TIGR4; 1:1 ratio of CSP-1:CSP-2 for BHN418) was added to the bacterial suspension and incubated at RT for 5 mins. The suspensions were then mixed with ~300 ng transforming DNA, incubated at 37°C, 5% CO<sub>2</sub> for two hours and plated on CBA plates supplemented with relevant antibiotics. Antibiotic resistant transformants were screened using colony PCR and confirmed by sequencing.</p><p id="P30">Transforming DNA for generating <italic>lgt::cm</italic> and <italic>palA::kan</italic> mutants were generated using overlap-extension PCR. Complementation and expression constructs were generated by inserting the target gene into the complementation plasmid pASR103 or pPEPY (<xref ref-type="bibr" rid="R64">64</xref>), which allows for integration of the construct at a chromosomal ectopic site. Plasmids used are listed in <xref ref-type="table" rid="T3">Table 3</xref>, while primers are listed in <xref ref-type="supplementary-material" rid="SD1">Supplementary Table 2</xref>.</p></sec><sec id="S12"><title>Cell culture</title><p id="P31">Detroit 562 (ATCC® CCL-138™; human pharyngeal carcinoma epithelial cells) were expanded and maintained in MEMα (Gibco™ 22561021) supplemented with 10% heat-inactivated FBS (HI-FBS; LabTech FB-1001/500 or Gibco 10438-026) at 37°C, 5% CO<sub>2</sub>. HEK-Blue™ hTLR2 reporter cells (Invivogen, hkb-htlr2) were expanded and maintained in DMEM (4.5 g/L glucose, 2mM glutamine, sodium pyruvate) supplemented with 10% HI-FBS at 37°C, 5% CO<sub>2</sub>. Per manufacturer’s instructions, DMEM growth medium was supplemented with 100 μg/ml normocin™ and/or 1X HEK-Blue™ Selection (Invivogen) where appropriate.</p></sec><sec id="S13"><title>NPE infections</title><p id="P32">Adherence-invasion infections of confluent Detroit 562 cells with <italic>S. pneumoniae</italic> strains were performed at MOI 20 (P1121/23F derived strains) or MOI 10 (all others) for 3 hours. Working bacterial stocks were thawed, centrifuged to remove freezing medium and resuspended in infection medium (MEMα with 1% HI-FBS) to the appropriate CFU. 1 ml bacterial suspension were added to each well containing confluent Detroit 562 cells. Plates were incubated statically at 37°C, 5% CO<sub>2</sub> for 3 hours, after which 10 μl of the supernatant were removed for CFU enumeration. For adherence assays, cells were washed thrice with PBS, lysed with cold 1% saponin (10 min incubation at 37°C, followed by vigorous pipetting), and 10 μl cell lysate removed for CFU enumeration. For invasion assays, cells were washed thrice with PBS, incubated with 0.5 ml infection medium supplemented with 200 μg/ml gentamicin at 37°C, 5% CO<sub>2</sub> for 1 hour to kill extracellular bacteria, followed by 3x PBS wash, lysis with 1% saponin and CFU enumeration. Experiments were performed at least thrice on different days (n≥3 biological replicates) with technical duplicates. Statistical significance was determined using one-way ANOVA with Bonferroni’s multiple comparison test.</p><p id="P33">To harvest RNA for qPCR, confluent Detroit 562 cells were treated with synthetic agonists or infected with <italic>S. pneumoniae</italic> strains at MOI 10 for 6 hours. Briefly, working bacterial stocks were thawed, centrifuged to remove freezing medium and resuspended in infection medium (MEMα with 1% HI-FBS) to the appropriate CFU. Bacterial suspensions, infection medium (negative control), or infection medium supplemented with synthetic agonists (20 μg/ml Poly(I:C)) (TLR3 agonist, Bio-Techne) were added to each flask. Flasks were incubated statically at 37°C, 5% CO<sub>2</sub> for 6 hours, after which 10 pl were removed for CFU enumeration. Detroit 562 cells were washed thrice with PBS and harvested by scraping into 300 pl <italic>RNAlater</italic> (ThermoFisher). For each treatment condition, RNA harvesting was performed at least thrice on different days (n≥3 biological replicates) without technical replicates.</p><p id="P34">For growth curve experiments, <italic>S. pneumoniae</italic> strains were seeded into 1 ml THY or 1 ml infection medium (MEMα with 1% HI-FBS, LabTech) with and without confluent Detroit 562 cells in 12-well plates at a similar CFU number as used in infection experiments. Plates were incubated at 37°C, 5% CO<sub>2</sub> for 7 hours, with aliquots taken for CFU enumeration every hour. CFU growth curves were performed at least thrice on different days (n&gt;3 biological replicates) without technical replicates. Statistical significance was determined using Student’s <italic>t-</italic>test assuming equal variance.</p></sec><sec id="S14"><title>qPCR</title><p id="P35">RNA from epithelial cells stored in <italic>RNAlater</italic> were extracted using RNeasy Mini kit (Qiagen) according to manufacturer instructions. Carryover DNA was removed with TURBO DNA-fr<italic>ee</italic> kit (Ambion), and cDNA generated using LunaScript® RT Supermix kit (NEB). qPCR was performed using Luna® Universal qPCR Master Mix (NEB) in technical triplicates with primers specific for <italic>GAPDH, CXCL10, IFNB1, IFNL1,</italic> and <italic>IFNL3</italic> (<xref ref-type="supplementary-material" rid="SD1">Supplementary Table 2</xref>). Whenever possible qPCR primers were designed to span exon-exon junctions. Cycling conditions are as follows: 95°C for 5 mins, 40 cycles of 95°C for 15 secs and 60.5°C for 45 secs, with a plate read at the end of each cycle. Data was analysed using the 2<sup>ΔΔCt</sup> method, with media only control and <italic>GAPDH</italic> levels for normalization. Statistical significance was determined using Student’s <italic>t-</italic>test assuming equal variance.</p></sec><sec id="S15"><title>HEK-Blue hTLR2 reporter assay</title><p id="P36">HEK-Blue™ hTLR2 secreted alkaline phosphatase (SEAP) reporter assays were performed according to manufacturer instructions (Invivogen, hkb-htlr2). Briefly, HEK-Blue™ hTLR2 cells, <italic>S. pneumoniae</italic> and control reagents were resuspended or diluted in pre-warmed HEK-Blue™ Detection medium (Invivogen). 5 x 10<sup>4</sup> HEK-Blue™ hTLR2 cells were mixed with 5 x 10<sup>5</sup> CFU <italic>S. pneumoniae</italic> (MOI 10) and incubated for 16 hours at 37°C, 5% CO<sub>2</sub>. SEAP activity was then measured spectroscopically at A620. 100 ng/ml of Pam2CSK4 and Pam<sub>3</sub>CSK<sub>4</sub> (TLR2 agonist, Bio-Techne) were used as positive controls, while bacterial-free medium was used as negative control. Experiments were performed at least thrice on different days (n≥3 biological replicates) with technical triplicates.</p><p id="P37">Statistical significance was determined using one-way ANOVA with Bonferroni’s multiple comparison test.</p></sec><sec id="S16"><title>Lipoprotein prediction using MEME suite</title><p id="P38">Amino acid sequences of thirty-nine published D39 lipoproteins were used with the motif discovery tool MEME to identify pneumococcal lipoprotein motif(s) (<xref ref-type="bibr" rid="R5">5</xref>, <xref ref-type="bibr" rid="R13">13</xref>, <xref ref-type="bibr" rid="R22">22</xref>). The top two MEME results were combined to obtain motif: L[LA][AS][AL]LXL[AV]A<bold>C</bold>[SG][NQS], a modified extension of the minimal lipobox motif LAG<bold>C</bold> (<xref ref-type="bibr" rid="R5">5</xref>).</p><p id="P39">The obtained motif was used with the motif scanning tool FIMO to identify lipoproteins in the genomes of <italic>S. pneumoniae</italic> TIGR4, BHN418 and D39, with the latter used for quality control (<xref ref-type="bibr" rid="R65">65</xref>). Match <italic>p</italic>-value was set to 0.001. FIMO results were further filtered with the following criteria: (i) presence of the lipidated cysteine residue in the motif, (ii) presence of motif in the first 70 a.a. of the sequence, iii) positive prediction as lipoprotein by SignalP-6.0 (<xref ref-type="bibr" rid="R66">66</xref>).</p></sec><sec id="S17"><title>Genomic analysis</title><p id="P40">Presence of <italic>palA</italic> and its associated genetic island were determined using Local-BLAST (BLASTN, TBLASTN) for the Malawian carriage dataset (n=51,379) and serotype 23F strain P1121 (<xref ref-type="bibr" rid="R67">67</xref>). The built-in BLAST tool on pubmlst.org was used for analysis of the BIGSdb dataset (<xref ref-type="bibr" rid="R49">49</xref>). BLASTN and TBLASTN tools on the NCBI database were used to identify <italic>palA</italic> and PalA homologues in non-pneumococcal species (<xref ref-type="bibr" rid="R67">67</xref>, <xref ref-type="bibr" rid="R68">68</xref>). BLAST results were exported in csv format and further analysed using R (v3.6.0) in RStudio (<ext-link ext-link-type="uri" xlink:href="http://www.rstudio.com/">http://www.rstudio.com/</ext-link>). Presence/absence of <italic>palA</italic> was annotated onto a Newick tree showing phylogeny of the Malawian carriage strains by metabolic type and visualized using iTOL (<xref ref-type="bibr" rid="R48">48</xref>, <xref ref-type="bibr" rid="R69">69</xref>). Potential gene functions were inferred through the results of BLASTP and NCBI Conserved Domain Database searches (<xref ref-type="bibr" rid="R67">67</xref>, <xref ref-type="bibr" rid="R68">68</xref>, <xref ref-type="bibr" rid="R70">70</xref>).</p><p id="P41">The BHN418 genome assembly was generated by combining long read sequencing (PacBio) and short read sequencing (Illumina) methods which resulted in a single contiguous chromosome of BHN418 of length 2,107,426 bp. <italic>De novo</italic> assembly was performing using the Unicycler v0.4.8 pipeline in bold mode, quality assessed using QUAST v5.1.0rc1 and annotated using Bakta v1.8.2 as described previously (<xref ref-type="bibr" rid="R71">71</xref>–<xref ref-type="bibr" rid="R74">74</xref>). TIGR4 sequencing reads were aligned to the BHN418 genome using Samtools v1.14 and visualised using IGV v2.16.1 (<xref ref-type="bibr" rid="R26">26</xref>, <xref ref-type="bibr" rid="R68">68</xref>).</p></sec><sec id="S18"><title>TLR2 transcriptional module analysis</title><p id="P42">TLR2-mediated transcriptional activity in Detroit 562 cells infected with TIGR4 and BHN418 for 3 hours were determined using published RNAseq data (<xref ref-type="bibr" rid="R2">2</xref>). We generated a transcriptional module reflective of TLR2 activity derived from genes overexpressed in fibroblasts stimulated with TLR2 agonists Pam2CSK4 and/or FSL-1 for 6 hours relative to unstimulated controls (&gt;1.5 fold; paired <italic>t</italic>-test with a of p&lt;0.05 without multiple testing correction) (Gene Expression Omnibus (GEO) dataset GSE92466) (<xref ref-type="supplementary-material" rid="SD1">Supplementary Table 1</xref>) (<xref ref-type="bibr" rid="R19">19</xref>). Module expression was determined by calculating the geometric mean expression of all constituent genes found in the analysed RNAseq dataset. Performance was validated using data derived from Acute Myeloid Leukemia cells (GEO datasets GSE92744) and CD14+ monocytes stimulated with Pam<sub>3</sub>CSK<sub>4</sub> (GEO dataset GSE78699) (<xref ref-type="supplementary-material" rid="SD1">Supplementary Figure 1</xref>) (<xref ref-type="bibr" rid="R75">75</xref>, <xref ref-type="bibr" rid="R76">76</xref>).</p></sec><sec id="S19"><title>Murine experiments</title><p id="P43">Outbred female CD1 mice (Charles River Laboratories) were inoculated intranasally under anaesthetic (isoflurane) with 1 x 10<sup>7</sup> CFU bacteria (n=6 for single inoculation colonisation and pneumonia model, n=7 for competition experiment). For colonisation experiments, nasal washes were performed 7 days post infection using 1 ml PBS. For pneumonia model, mice were sacrificed 24 hpi and bacteria recovered from the blood and homogenized lungs. CFU numbers were enumerated using CBA supplemented with 4 μg/ml gentamicin, with additional 250 μg/ml kanamycin where appropriate. All animal procedures were approved by the local ethical review process and conducted in accordance with the relevant UK Home Office approved project license (PPL70/6510). Mice were housed for at least one week under standard conditions before use. Randomisation or blinding was not performed for these experiments. Statistical significance was determined using Mann-Whitney test.</p></sec></sec><sec sec-type="supplementary-material" id="SM"><title>Supplementary Material</title><supplementary-material content-type="local-data" id="SD1"><label>Supplemental materials</label><media xlink:href="EMS189900-supplement-Supplemental_materials.pdf" mimetype="application" mime-subtype="pdf" id="d99aAdEbB" position="anchor"/></supplementary-material></sec></body><back><ack id="S20"><title>Acknowledgements</title><p>This study was funded by a Medical Research Council grant (MR/T016329/1) awarded to RSH and JSB which supported JMC and CMW. JMC and MB were also supported by funding from NIHR Global Health Research Unit on Mucosal Pathogens at UCL, commissioned by the National Institute for Health Research using Official Development Assistance (ODA) funding. GP is supported by funding from the UCLH NIHR Biomedical Research Centre. RSH is a NIHR Senior Investigator. The views expressed are those of the authors and not necessarily those of the NIHR.</p></ack><sec id="S21" sec-type="data-availability"><title>Data availability</title><p id="P44">BHN418 genome was deposited to NCBI with accession number PRJNA1022026. TIGR4 sequencing reads were downloaded from NCBI Sequence Reads Archive (accession SRX6259281), while P1121 reads were downloaded from the EMBL-EBI database (accession ERS1072059) (<xref ref-type="bibr" rid="R77">77</xref>, <xref ref-type="bibr" rid="R78">78</xref>). D39 and TIGR4 whole genome assemblies were downloaded from NCBI GenBank database (accession numbers CP000410.2 and AE005672.3, respectively) (<xref ref-type="bibr" rid="R79">79</xref>). All other genomic sequences used were hosted on the PubMLST Pneumococcal Genome Library (<ext-link ext-link-type="uri" xlink:href="https://pubmlst.org/organisms/streptococcus-pneumoniae/pgl">https://pubmlst.org/organisms/streptococcus-pneumoniae/pgl</ext-link>) (<xref ref-type="bibr" rid="R48">48</xref>, <xref ref-type="bibr" rid="R49">49</xref>). RNAseq data used in the TLR2 transcriptional module expression analysis were obtained from the ArrayExpress database (accession E-MTAB-7841) (<xref ref-type="bibr" rid="R6">6</xref>).</p></sec><ref-list><ref id="R1"><label>1</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Weiser</surname><given-names>JN</given-names></name><name><surname>Ferreira</surname><given-names>DM</given-names></name><name><surname>Paton</surname><given-names>JC</given-names></name></person-group><article-title><italic>Streptococcus pneumoniae</italic>: Transmission, colonization and invasion</article-title><source>Nat Rev Microbiol</source><year>2018</year><volume>16</volume><fpage>355</fpage><lpage>367</lpage><pub-id pub-id-type="pmcid">PMC5949087</pub-id><pub-id pub-id-type="pmid">29599457</pub-id><pub-id pub-id-type="doi">10.1038/s41579-018-0001-8</pub-id></element-citation></ref><ref id="R2"><label>2</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Weight</surname><given-names>CM</given-names></name><name><surname>Venturini</surname><given-names>C</given-names></name><name><surname>Pojar</surname><given-names>S</given-names></name><name><surname>Jochems</surname><given-names>SP</given-names></name><name><surname>Reine</surname><given-names>J</given-names></name><name><surname>Nikolaou</surname><given-names>E</given-names></name><name><surname>Solorzano</surname><given-names>C</given-names></name><name><surname>Noursadeghi</surname><given-names>M</given-names></name><name><surname>Brown</surname><given-names>JS</given-names></name><name><surname>Ferreira</surname><given-names>DM</given-names></name><name><surname>Heyderman</surname><given-names>RS</given-names></name></person-group><article-title>Microinvasion by <italic>Streptococcus pneumoniae</italic> induces epithelial innate immunity during colonisation at the human mucosal surface</article-title><source>Nat Commun</source><year>2019</year><volume>10</volume><elocation-id>3060</elocation-id><pub-id pub-id-type="pmcid">PMC6635362</pub-id><pub-id pub-id-type="pmid">31311921</pub-id><pub-id pub-id-type="doi">10.1038/s41467-019-11005-2</pub-id></element-citation></ref><ref id="R3"><label>3</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jochems</surname><given-names>SP</given-names></name><name><surname>de Ruiter</surname><given-names>K</given-names></name><name><surname>Solorzano</surname><given-names>C</given-names></name><name><surname>Voskamp</surname><given-names>A</given-names></name><name><surname>Mitsi</surname><given-names>E</given-names></name><name><surname>Nikolaou</surname><given-names>E</given-names></name><name><surname>Carniel</surname><given-names>BF</given-names></name><name><surname>Pojar</surname><given-names>S</given-names></name><name><surname>German</surname><given-names>EL</given-names></name><name><surname>Reine</surname><given-names>J</given-names></name><name><surname>Soares-Schanoski</surname><given-names>A</given-names></name><etal/></person-group><article-title>Innate and adaptive nasal mucosal immune responses following experimental human pneumococcal colonization</article-title><source>J Clin Invest</source><year>2019</year><volume>129</volume><fpage>4523</fpage><lpage>4538</lpage><pub-id pub-id-type="pmcid">PMC6763269</pub-id><pub-id pub-id-type="pmid">31361601</pub-id><pub-id pub-id-type="doi">10.1172/JCI128865</pub-id></element-citation></ref><ref id="R4"><label>4</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Trimble</surname><given-names>A</given-names></name><name><surname>Connor</surname><given-names>V</given-names></name><name><surname>Robinson</surname><given-names>RE</given-names></name><name><surname>McLenaghan</surname><given-names>D</given-names></name><name><surname>Hancock</surname><given-names>CA</given-names></name><name><surname>Wang</surname><given-names>D</given-names></name><name><surname>Gordon</surname><given-names>SB</given-names></name><name><surname>Ferreira</surname><given-names>DM</given-names></name><name><surname>Wright</surname><given-names>AD</given-names></name><name><surname>Collins</surname><given-names>AM</given-names></name></person-group><article-title>Pneumococcal colonisation is an asymptomatic event in healthy adults using an experimental human colonisation model</article-title><source>PLoS One</source><year>2020</year><volume>15</volume><elocation-id>e0229558</elocation-id><pub-id pub-id-type="pmcid">PMC7064211</pub-id><pub-id pub-id-type="pmid">32155176</pub-id><pub-id pub-id-type="doi">10.1371/journal.pone.0229558</pub-id></element-citation></ref><ref id="R5"><label>5</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kohler</surname><given-names>S</given-names></name><name><surname>VoR</surname><given-names>F</given-names></name><name><surname>Gomez Mejia</surname><given-names>A</given-names></name><name><surname>Brown</surname><given-names>JS</given-names></name><name><surname>Hammerschmidt</surname><given-names>S</given-names></name></person-group><article-title>Pneumococcal lipoproteins involved in bacterial fitness, virulence, and immune evasion</article-title><source>FEBS Lett</source><year>2016</year><volume>590</volume><fpage>3820</fpage><lpage>3839</lpage><pub-id pub-id-type="pmid">27508940</pub-id></element-citation></ref><ref id="R6"><label>6</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mitchell</surname><given-names>AM</given-names></name><name><surname>Mitchell</surname><given-names>TJ</given-names></name></person-group><article-title><italic>Streptococcus pneumoniae:</italic> Virulence factors and variation</article-title><source>Clin Microbiol Infect</source><year>2010</year><volume>16</volume><fpage>411</fpage><lpage>418</lpage><pub-id pub-id-type="pmid">20132250</pub-id></element-citation></ref><ref id="R7"><label>7</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Moffitt</surname><given-names>K</given-names></name><name><surname>Howard</surname><given-names>A</given-names></name><name><surname>Martin</surname><given-names>S</given-names></name><name><surname>Cheung</surname><given-names>E</given-names></name><name><surname>Herd</surname><given-names>M</given-names></name><name><surname>Basset</surname><given-names>A</given-names></name><name><surname>Malley</surname><given-names>R</given-names></name></person-group><article-title>Th17-mediated protection against pneumococcal carriage by a whole-cell vaccine is dependent on Toll-like receptor 2 and surface lipoproteins</article-title><source>Clin Vaccine Immunol</source><year>2015</year><volume>22</volume><fpage>909</fpage><lpage>916</lpage><pub-id pub-id-type="pmcid">PMC4519727</pub-id><pub-id pub-id-type="pmid">26041040</pub-id><pub-id pub-id-type="doi">10.1128/CVI.00118-15</pub-id></element-citation></ref><ref id="R8"><label>8</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jang</surname><given-names>A-Y</given-names></name><name><surname>Ahn</surname><given-names>KB</given-names></name><name><surname>Zhi</surname><given-names>Y</given-names></name><name><surname>Ji</surname><given-names>H</given-names></name><name><surname>Zhang</surname><given-names>J</given-names></name><name><surname>Han</surname><given-names>SH</given-names></name><name><surname>Guo</surname><given-names>H</given-names></name><name><surname>Lim</surname><given-names>S</given-names></name><name><surname>Song</surname><given-names>JY</given-names></name><name><surname>Lim</surname><given-names>JH</given-names></name><name><surname>Seo</surname><given-names>HS</given-names></name></person-group><article-title>Serotype-independent protection against invasive pneumococcal infections conferred by live vaccine with <italic>lgt</italic> deletion</article-title><source>Front Immunol</source><year>2019</year><volume>10</volume><fpage>1212</fpage><pub-id pub-id-type="pmcid">PMC6549034</pub-id><pub-id pub-id-type="pmid">31191555</pub-id><pub-id pub-id-type="doi">10.3389/fimmu.2019.01212</pub-id></element-citation></ref><ref id="R9"><label>9</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tomlinson</surname><given-names>G</given-names></name><name><surname>Chimalapati</surname><given-names>S</given-names></name><name><surname>Pollard</surname><given-names>T</given-names></name><name><surname>Lapp</surname><given-names>T</given-names></name><name><surname>Cohen</surname><given-names>J</given-names></name><name><surname>Camberlein</surname><given-names>E</given-names></name><name><surname>Stafford</surname><given-names>S</given-names></name><name><surname>Periselneris</surname><given-names>J</given-names></name><name><surname>Aldridge</surname><given-names>C</given-names></name><name><surname>Vollmer</surname><given-names>W</given-names></name><name><surname>Picard</surname><given-names>C</given-names></name><etal/></person-group><article-title>TLR-mediated inflammatory responses to <italic>Streptococcus pneumoniae</italic> are highly dependent on surface expression of bacterial lipoproteins</article-title><source>J Immunol</source><year>2020</year><volume>193</volume><fpage>3736</fpage><lpage>3745</lpage><pub-id pub-id-type="pmcid">PMC4170674</pub-id><pub-id pub-id-type="pmid">25172490</pub-id><pub-id pub-id-type="doi">10.4049/jimmunol.1401413</pub-id></element-citation></ref><ref id="R10"><label>10</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Barendt</surname><given-names>SM</given-names></name><name><surname>Sham</surname><given-names>L</given-names></name><name><surname>Winkler</surname><given-names>ME</given-names></name></person-group><article-title>Characterization of mutants deficient in the L,D -Carboxypeptidase (DacB) and WalRK (VicRK) regulon, involved in peptidoglycan maturation of <italic>Streptococcus pneumoniae</italic> serotype 2 strain D39</article-title><source>J Bacteriol</source><year>2011</year><volume>193</volume><fpage>2290</fpage><lpage>2300</lpage></element-citation></ref><ref id="R11"><label>11</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Russell</surname><given-names>H</given-names></name><name><surname>Tharpe</surname><given-names>JA</given-names></name><name><surname>Wells</surname><given-names>DE</given-names></name><name><surname>White</surname><given-names>EH</given-names></name><name><surname>Johnson</surname><given-names>JE</given-names></name></person-group><article-title>Monoclonal antibody recognizing a species-specific protein from <italic>Streptococcus pneumoniae</italic></article-title><source>J Clin Microbiol</source><year>1990</year><volume>28</volume><fpage>2191</fpage><lpage>2195</lpage><pub-id pub-id-type="pmcid">PMC268145</pub-id><pub-id pub-id-type="pmid">2229341</pub-id><pub-id pub-id-type="doi">10.1128/jcm.28.10.2191-2195.1990</pub-id></element-citation></ref><ref id="R12"><label>12</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lawrence</surname><given-names>MC</given-names></name><name><surname>Pilling</surname><given-names>PA</given-names></name><name><surname>Epa</surname><given-names>VC</given-names></name><name><surname>Berry</surname><given-names>AM</given-names></name><name><surname>Ogunniyi</surname><given-names>AD</given-names></name><name><surname>Paton</surname><given-names>JC</given-names></name></person-group><article-title>The crystal structure of pneumococcal surface antigen PsaA reveals a metalbinding site and a novel structure for a putative ABC-type binding protein</article-title><source>Curr Biol</source><year>1998</year><volume>6</volume><fpage>1553</fpage><lpage>1561</lpage><pub-id pub-id-type="pmid">9862808</pub-id></element-citation></ref><ref id="R13"><label>13</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pribyl</surname><given-names>T</given-names></name><name><surname>Moche</surname><given-names>M</given-names></name><name><surname>Dreisbach</surname><given-names>A</given-names></name><name><surname>Bijlsma</surname><given-names>JJE</given-names></name><name><surname>Saleh</surname><given-names>M</given-names></name><name><surname>Abdullah</surname><given-names>MR</given-names></name><name><surname>Hecker</surname><given-names>M</given-names></name><name><surname>van Dijl</surname><given-names>JM</given-names></name><name><surname>Becher</surname><given-names>D</given-names></name><name><surname>Hammerschmidt</surname><given-names>S</given-names></name></person-group><article-title>Influence of impaired lipoprotein biogenesis on surface and exoproteome of <italic>Streptococcus pneumoniae</italic></article-title><source>J Proteome Res</source><year>2014</year><volume>13</volume><fpage>650</fpage><lpage>667</lpage><pub-id pub-id-type="pmid">24387739</pub-id></element-citation></ref><ref id="R14"><label>14</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chimalapati</surname><given-names>S</given-names></name><name><surname>Cohen</surname><given-names>JM</given-names></name><name><surname>Camberlein</surname><given-names>E</given-names></name><name><surname>MacDonald</surname><given-names>N</given-names></name><name><surname>Durmort</surname><given-names>C</given-names></name><name><surname>Vernet</surname><given-names>T</given-names></name><name><surname>Hermans</surname><given-names>PWM</given-names></name><name><surname>Mitchell</surname><given-names>T</given-names></name><name><surname>Brown</surname><given-names>JS</given-names></name></person-group><article-title>Effects of deletion of the <italic>Streptococcus pneumoniae</italic> lipoprotein diacylglyceryl transferase gene <italic>lgt</italic> on ABC transporter function and on growth <italic>in vivo</italic></article-title><source>PLoS One</source><year>2012</year><volume>7</volume><elocation-id>e41393</elocation-id><pub-id pub-id-type="pmcid">PMC3404074</pub-id><pub-id pub-id-type="pmid">22911788</pub-id><pub-id pub-id-type="doi">10.1371/journal.pone.0041393</pub-id></element-citation></ref><ref id="R15"><label>15</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Aaberge</surname><given-names>IS</given-names></name><name><surname>Eng</surname><given-names>J</given-names></name><name><surname>Lermark</surname><given-names>G</given-names></name><name><surname>Lovik</surname><given-names>M</given-names></name></person-group><article-title>Virulence of Streptococcus pneumoniae in mice: a standardized method for preparation and frozen storage of the experimental bacterial inoculum</article-title><source>Microb Pathog</source><year>1995</year><volume>18</volume><fpage>141</fpage><lpage>152</lpage><pub-id pub-id-type="pmid">7643743</pub-id></element-citation></ref><ref id="R16"><label>16</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Browall</surname><given-names>S</given-names></name><name><surname>Norman</surname><given-names>M</given-names></name><name><surname>Tangrot</surname><given-names>J</given-names></name><name><surname>Galanis</surname><given-names>I</given-names></name><name><surname>Sjostrom</surname><given-names>K</given-names></name><name><surname>Dagerhamn</surname><given-names>J</given-names></name><name><surname>Hellberg</surname><given-names>C</given-names></name><name><surname>Pathak</surname><given-names>A</given-names></name><name><surname>Spadafina</surname><given-names>T</given-names></name><name><surname>Sandgren</surname><given-names>A</given-names></name><name><surname>Battig</surname><given-names>P</given-names></name><etal/></person-group><article-title>Intraclonal variations among <italic>Streptococcus pneumoniae</italic> isolates influence the likelihood of invasive disease in children</article-title><source>J Infect Dis</source><year>2014</year><volume>209</volume><fpage>377</fpage><lpage>388</lpage><pub-id pub-id-type="pmcid">PMC4014860</pub-id><pub-id pub-id-type="pmid">24009156</pub-id><pub-id pub-id-type="doi">10.1093/infdis/jit481</pub-id></element-citation></ref><ref id="R17"><label>17</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sleeman</surname><given-names>KL</given-names></name><name><surname>Griffiths</surname><given-names>D</given-names></name><name><surname>Shackley</surname><given-names>F</given-names></name><name><surname>Diggle</surname><given-names>L</given-names></name><name><surname>Gupta</surname><given-names>S</given-names></name><name><surname>Maiden</surname><given-names>MC</given-names></name><name><surname>Moxon</surname><given-names>ER</given-names></name><name><surname>Crook</surname><given-names>DW</given-names></name><name><surname>Peto</surname><given-names>TEA</given-names></name></person-group><article-title>Capsular serotype-specific attack rates and duration of carriage of <italic>Streptococcus pneumoniae</italic> in a population of children</article-title><source>J Infect Dis</source><year>2006</year><volume>194</volume><fpage>682</fpage><lpage>688</lpage><pub-id pub-id-type="pmid">16897668</pub-id></element-citation></ref><ref id="R18"><label>18</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Richard</surname><given-names>AL</given-names></name><name><surname>Siegel</surname><given-names>SJ</given-names></name><name><surname>Erikson</surname><given-names>J</given-names></name><name><surname>Weiser</surname><given-names>JN</given-names></name></person-group><article-title>TLR2 signaling decreases transmission of Streptococcus pneumoniae by limiting bacterial shedding in an infant mouse Influenza A co-infection model</article-title><source>PLoS Pathog</source><year>2014</year><volume>10</volume><elocation-id>e1004339</elocation-id><pub-id pub-id-type="pmcid">PMC4148449</pub-id><pub-id pub-id-type="pmid">25166617</pub-id><pub-id pub-id-type="doi">10.1371/journal.ppat.1004339</pub-id></element-citation></ref><ref id="R19"><label>19</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Della Mina</surname><given-names>E</given-names></name><name><surname>Borghesi</surname><given-names>A</given-names></name><name><surname>Zhou</surname><given-names>H</given-names></name><name><surname>Bougarn</surname><given-names>S</given-names></name><name><surname>Boughorbel</surname><given-names>S</given-names></name><name><surname>Israel</surname><given-names>L</given-names></name><name><surname>Meloni</surname><given-names>I</given-names></name><name><surname>Chrabieh</surname><given-names>M</given-names></name><name><surname>Ling</surname><given-names>Y</given-names></name><name><surname>Itan</surname><given-names>Y</given-names></name><name><surname>Renieri</surname><given-names>A</given-names></name><etal/></person-group><article-title>Inherited human IRAK-1 deficiency selectively impairs TLR signaling in fibroblasts</article-title><source>Proc Natl Acad Sci</source><year>2017</year><volume>114</volume><fpage>E514</fpage><lpage>E523</lpage><pub-id pub-id-type="pmcid">PMC5278481</pub-id><pub-id pub-id-type="pmid">28069966</pub-id><pub-id pub-id-type="doi">10.1073/pnas.1620139114</pub-id></element-citation></ref><ref id="R20"><label>20</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname><given-names>KS</given-names></name><name><surname>Scanga</surname><given-names>CA</given-names></name><name><surname>Bachelder</surname><given-names>EM</given-names></name><name><surname>Chen</surname><given-names>Q</given-names></name><name><surname>Snapper</surname><given-names>CM</given-names></name></person-group><article-title>TLR2 synergizes with both TLR4 and TLR9 for induction of the MyD88-dependent splenic cytokine and chemokine response to <italic>Streptococcus pneumoniae</italic></article-title><source>Cell Immunol</source><year>2007</year><volume>245</volume><fpage>103</fpage><lpage>110</lpage><pub-id pub-id-type="pmcid">PMC2691573</pub-id><pub-id pub-id-type="pmid">17521621</pub-id><pub-id pub-id-type="doi">10.1016/j.cellimm.2007.04.003</pub-id></element-citation></ref><ref id="R21"><label>21</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dessing</surname><given-names>MC</given-names></name><name><surname>Hirst</surname><given-names>RA</given-names></name><name><surname>de Vos</surname><given-names>AF</given-names></name><name><surname>van der Poll</surname><given-names>T</given-names></name></person-group><article-title>Role of Toll-like receptors 2 and 4 in pulmonary inflammation and injury induced by pneumolysin in mice</article-title><source>PLoS One</source><year>2009</year><volume>4</volume><elocation-id>e7993</elocation-id><pub-id pub-id-type="pmcid">PMC2776357</pub-id><pub-id pub-id-type="pmid">19956717</pub-id><pub-id pub-id-type="doi">10.1371/journal.pone.0007993</pub-id></element-citation></ref><ref id="R22"><label>22</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bailey</surname><given-names>TL</given-names></name><name><surname>Johnson</surname><given-names>J</given-names></name><name><surname>Grant</surname><given-names>CE</given-names></name><name><surname>Noble</surname><given-names>WS</given-names></name></person-group><article-title>The MEME Suite</article-title><source>Nucleic Acids Res</source><year>2015</year><volume>43</volume><fpage>W39</fpage><lpage>W49</lpage><pub-id pub-id-type="pmcid">PMC4489269</pub-id><pub-id pub-id-type="pmid">25953851</pub-id><pub-id pub-id-type="doi">10.1093/nar/gkv416</pub-id></element-citation></ref><ref id="R23"><label>23</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wilkens</surname><given-names>S</given-names></name></person-group><article-title>Structure and mechanism of ABC transporters</article-title><source>F1000Prime Rep</source><year>2015</year><volume>7</volume><fpage>14</fpage><pub-id pub-id-type="pmcid">PMC4338842</pub-id><pub-id pub-id-type="pmid">25750732</pub-id><pub-id pub-id-type="doi">10.12703/P7-14</pub-id></element-citation></ref><ref id="R24"><label>24</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rosenow</surname><given-names>C</given-names></name><name><surname>Maniar</surname><given-names>M</given-names></name><name><surname>Trias</surname><given-names>J</given-names></name></person-group><article-title>Regulation of the alpha-galactosidase activity in <italic>Streptococcus pneumoniae:</italic> Characterization of the raffinose utilization system</article-title><source>Genome Res</source><year>1999</year><volume>9</volume><fpage>1189</fpage><lpage>1197</lpage><pub-id pub-id-type="pmcid">PMC311000</pub-id><pub-id pub-id-type="pmid">10613841</pub-id><pub-id pub-id-type="doi">10.1101/gr.9.12.1189</pub-id></element-citation></ref><ref id="R25"><label>25</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Minhas</surname><given-names>V</given-names></name><name><surname>Harvey</surname><given-names>RM</given-names></name><name><surname>McAllister</surname><given-names>LJ</given-names></name><name><surname>Seemann</surname><given-names>T</given-names></name><name><surname>Syme</surname><given-names>AE</given-names></name><name><surname>Baines</surname><given-names>SL</given-names></name><name><surname>Paton</surname><given-names>JC</given-names></name><name><surname>Trappetti</surname><given-names>C</given-names></name></person-group><article-title>Capacity to utilize raffinose dictates pneumococcal disease phenotype</article-title><source>MBio</source><year>2019</year><volume>10</volume><fpage>e02596</fpage><lpage>18</lpage><pub-id pub-id-type="pmcid">PMC6336424</pub-id><pub-id pub-id-type="pmid">30647157</pub-id><pub-id pub-id-type="doi">10.1128/mBio.02596-18</pub-id></element-citation></ref><ref id="R26"><label>26</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tettelin</surname><given-names>H</given-names></name><name><surname>Nelson</surname><given-names>KE</given-names></name><name><surname>Paulsen</surname><given-names>IT</given-names></name><name><surname>Eisen</surname><given-names>JA</given-names></name><name><surname>Read</surname><given-names>TD</given-names></name><name><surname>Peterson</surname><given-names>S</given-names></name><name><surname>Heidelberg</surname><given-names>J</given-names></name><name><surname>DeBoy</surname><given-names>RT</given-names></name><name><surname>Haft</surname><given-names>DH</given-names></name><name><surname>Dodson</surname><given-names>RJ</given-names></name><name><surname>Durkin</surname><given-names>AS</given-names></name><etal/></person-group><article-title>Complete genome sequence of a virulent isolate of <italic>Streptococcus pneumoniae</italic></article-title><source>Science (80-)</source><year>2001</year><volume>293</volume><fpage>498</fpage><lpage>506</lpage><pub-id pub-id-type="pmid">11463916</pub-id></element-citation></ref><ref id="R27"><label>27</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Spellerberg</surname><given-names>B</given-names></name><name><surname>Cundell</surname><given-names>DR</given-names></name><name><surname>Sandros</surname><given-names>J</given-names></name><name><surname>Pearce</surname><given-names>BJ</given-names></name><name><surname>Idanpaan-Heikkila</surname><given-names>I</given-names></name><name><surname>Rosenow</surname><given-names>C</given-names></name><name><surname>Masure</surname><given-names>HR</given-names></name></person-group><article-title>Pyruvate oxidase, as a determinant of virulence in Streptococcus pneumoniae</article-title><source>Mol Microbiol</source><year>1996</year><volume>19</volume><fpage>803</fpage><lpage>813</lpage><pub-id pub-id-type="pmid">8820650</pub-id></element-citation></ref><ref id="R28"><label>28</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Khandavilli</surname><given-names>S</given-names></name><name><surname>Homer</surname><given-names>KA</given-names></name><name><surname>Yuste</surname><given-names>J</given-names></name><name><surname>Basavanna</surname><given-names>S</given-names></name><name><surname>Mitchell</surname><given-names>T</given-names></name><name><surname>Brown</surname><given-names>JS</given-names></name></person-group><article-title>Maturation of <italic>Streptococcus pneumoniae</italic> lipoproteins by a type II signal peptidase is required for ABC transporter function and full virulence</article-title><source>Mol Microbiol</source><year>2008</year><volume>67</volume><fpage>541</fpage><lpage>557</lpage><pub-id pub-id-type="pmcid">PMC2228790</pub-id><pub-id pub-id-type="pmid">18086214</pub-id><pub-id pub-id-type="doi">10.1111/j.1365-2958.2007.06065.x</pub-id></element-citation></ref><ref id="R29"><label>29</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dintilhac</surname><given-names>A</given-names></name><name><surname>Claverys</surname><given-names>J-P</given-names></name></person-group><article-title>The adc locus, which affects competence for genetic transformation in <italic>Streptococcus pneumoniae</italic>, encodes an ABC transporter with a putative lipoprotein homologous to a family of streptococcal adhesins</article-title><source>Res Microbiol</source><year>1997</year><volume>148</volume><fpage>119</fpage><lpage>131</lpage><pub-id pub-id-type="pmid">9765793</pub-id></element-citation></ref><ref id="R30"><label>30</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Loisel</surname><given-names>E</given-names></name><name><surname>Jacquamet</surname><given-names>L</given-names></name><name><surname>Serre</surname><given-names>L</given-names></name><name><surname>Bauvois</surname><given-names>C</given-names></name><name><surname>Ferrer</surname><given-names>JL</given-names></name><name><surname>Vernet</surname><given-names>T</given-names></name><name><surname>Di Guilmi</surname><given-names>AM</given-names></name><name><surname>Durmort</surname><given-names>C</given-names></name></person-group><article-title>AdcAII, a new pneumococcal Zn-binding protein homologous with ABC transporters: biochemical and structural analysis</article-title><source>J Mol Biol</source><year>2008</year><volume>381</volume><fpage>594</fpage><lpage>606</lpage><pub-id pub-id-type="pmid">18632116</pub-id></element-citation></ref><ref id="R31"><label>31</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Alloing</surname><given-names>G</given-names></name><name><surname>de Philip</surname><given-names>P</given-names></name><name><surname>Claverys</surname><given-names>J-P</given-names></name></person-group><article-title>Three highly homologous membrane-bound lipoproteins participate in oligopeptide transport by the Ami system of the Gram-positive <italic>Streptococcus pneumoniae</italic></article-title><source>J Mol Biol</source><year>1994</year><volume>241</volume><fpage>44</fpage><lpage>58</lpage><pub-id pub-id-type="pmid">8051706</pub-id></element-citation></ref><ref id="R32"><label>32</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Alloing</surname><given-names>G</given-names></name><name><surname>Trombe</surname><given-names>M</given-names></name><name><surname>Claverys</surname><given-names>J-P</given-names></name></person-group><article-title>The <italic>ami</italic> locus of the Gram-positive bacterium <italic>Streptococcus pneumoniae</italic> is similar to binding protein-dependent transport operons of Gram-negative bacteria</article-title><source>Mol Microbiol</source><year>1990</year><volume>4</volume><fpage>633</fpage><lpage>644</lpage><pub-id pub-id-type="pmid">2352474</pub-id></element-citation></ref><ref id="R33"><label>33</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Farshchi Andisi</surname><given-names>V</given-names></name><name><surname>Hinojosa</surname><given-names>CA</given-names></name><name><surname>de Jong</surname><given-names>A</given-names></name><name><surname>Kuipers</surname><given-names>OP</given-names></name><name><surname>Orihuela</surname><given-names>CJ</given-names></name><name><surname>Bijlsma</surname><given-names>JJE</given-names></name></person-group><article-title>Pneumococcal gene complex involved in resistance to extracellular oxidative stress</article-title><source>Infect Immun</source><year>2011</year><volume>80</volume><fpage>1037</fpage><lpage>1049</lpage><pub-id pub-id-type="pmcid">PMC3294666</pub-id><pub-id pub-id-type="pmid">22215735</pub-id><pub-id pub-id-type="doi">10.1128/IAI.05563-11</pub-id></element-citation></ref><ref id="R34"><label>34</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Saleh</surname><given-names>M</given-names></name><name><surname>Bartual</surname><given-names>SG</given-names></name><name><surname>Abdullah</surname><given-names>MR</given-names></name><name><surname>Jensch</surname><given-names>I</given-names></name><name><surname>Asmat</surname><given-names>TM</given-names></name><name><surname>Petruschka</surname><given-names>L</given-names></name><name><surname>Pribyl</surname><given-names>T</given-names></name><name><surname>Gellert</surname><given-names>M</given-names></name><name><surname>Lillig</surname><given-names>CH</given-names></name><name><surname>Antelmann</surname><given-names>H</given-names></name><name><surname>Hermoso</surname><given-names>JA</given-names></name><etal/></person-group><article-title>Molecular architecture of <italic>Streptococcus pneumoniae</italic> surface thioredoxin-fold lipoproteins crucial for extracellular oxidative stress resistance and maintenance of virulence</article-title><source>EMBO Mol Med</source><year>2013</year><volume>5</volume><fpage>1852</fpage><lpage>1870</lpage><pub-id pub-id-type="pmcid">PMC3914529</pub-id><pub-id pub-id-type="pmid">24136784</pub-id><pub-id pub-id-type="doi">10.1002/emmm.201202435</pub-id></element-citation></ref><ref id="R35"><label>35</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hartel</surname><given-names>T</given-names></name><name><surname>Klein</surname><given-names>M</given-names></name><name><surname>Koedel</surname><given-names>U</given-names></name><name><surname>Rohde</surname><given-names>M</given-names></name><name><surname>Petruschka</surname><given-names>L</given-names></name><name><surname>Hammerschmidt</surname><given-names>S</given-names></name></person-group><article-title>Impact of glutamine transporters on pneumococcal fitness under infection-related conditions</article-title><source>Infect Immun</source><year>2011</year><volume>79</volume><fpage>44</fpage><lpage>58</lpage><pub-id pub-id-type="pmcid">PMC3019899</pub-id><pub-id pub-id-type="pmid">21078855</pub-id><pub-id pub-id-type="doi">10.1128/IAI.00855-10</pub-id></element-citation></ref><ref id="R36"><label>36</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Potter</surname><given-names>AJ</given-names></name><name><surname>Trappetti</surname><given-names>C</given-names></name><name><surname>Paton</surname><given-names>JC</given-names></name></person-group><article-title><italic>Streptococcus pneumoniae</italic> uses glutathione to defend against oxidative stress and metal ion toxicity</article-title><source>J Bacteriol</source><year>2012</year><volume>194</volume><fpage>6248</fpage><lpage>6254</lpage><pub-id pub-id-type="pmcid">PMC3486410</pub-id><pub-id pub-id-type="pmid">22984260</pub-id><pub-id pub-id-type="doi">10.1128/JB.01393-12</pub-id></element-citation></ref><ref id="R37"><label>37</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Basavanna</surname><given-names>S</given-names></name><name><surname>Khandavilli</surname><given-names>S</given-names></name><name><surname>Yuste</surname><given-names>J</given-names></name><name><surname>Cohen</surname><given-names>JM</given-names></name><name><surname>Hosie</surname><given-names>AHF</given-names></name><name><surname>Webb</surname><given-names>AJ</given-names></name><name><surname>Thomas</surname><given-names>GH</given-names></name><name><surname>Brown</surname><given-names>JS</given-names></name></person-group><article-title>Screening of <italic>Streptococcus pneumoniae</italic> ABC transporter mutants demonstrates that LivJHMGF, a branched-chain amino acid ABC transporter, is necessary for disease pathogenesis</article-title><source>Infect Immun</source><year>2009</year><volume>77</volume><fpage>3412</fpage><lpage>3423</lpage><pub-id pub-id-type="pmcid">PMC2715661</pub-id><pub-id pub-id-type="pmid">19470745</pub-id><pub-id pub-id-type="doi">10.1128/IAI.01543-08</pub-id></element-citation></ref><ref id="R38"><label>38</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Weinrauch</surname><given-names>Y</given-names></name><name><surname>Lacks</surname><given-names>SA</given-names></name></person-group><article-title>Nonsense mutations in the amylomaltase gene and other loci in <italic>Streptococcus pneumoniae</italic></article-title><source>Mol Gen Genet</source><year>1981</year><volume>183</volume><fpage>7</fpage><lpage>12</lpage><pub-id pub-id-type="pmid">6460154</pub-id></element-citation></ref><ref id="R39"><label>39</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Basavanna</surname><given-names>S</given-names></name><name><surname>Chimalapati</surname><given-names>S</given-names></name><name><surname>Maqbool</surname><given-names>A</given-names></name><name><surname>Rubbo</surname><given-names>B</given-names></name><name><surname>Yuste</surname><given-names>J</given-names></name><name><surname>Wilson</surname><given-names>RJ</given-names></name><name><surname>Hosie</surname><given-names>A</given-names></name><name><surname>Ogunniyi</surname><given-names>AD</given-names></name><name><surname>Paton</surname><given-names>JC</given-names></name><name><surname>Thomas</surname><given-names>G</given-names></name><name><surname>Brown</surname><given-names>JS</given-names></name></person-group><article-title>The effects of methionine acquisition and synthesis on <italic>Streptococcus pneumoniae</italic> growth and virulence</article-title><source>PLoS One</source><year>2013</year><volume>8</volume><elocation-id>e49638</elocation-id><pub-id pub-id-type="pmcid">PMC3551916</pub-id><pub-id pub-id-type="pmid">23349662</pub-id><pub-id pub-id-type="doi">10.1371/journal.pone.0049638</pub-id></element-citation></ref><ref id="R40"><label>40</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Adamou</surname><given-names>JE</given-names></name><name><surname>Heinrichs</surname><given-names>JH</given-names></name><name><surname>Erwin</surname><given-names>AL</given-names></name><name><surname>Walsh</surname><given-names>W</given-names></name><name><surname>Gayle</surname><given-names>T</given-names></name><name><surname>Dormitzer</surname><given-names>M</given-names></name><name><surname>Dagan</surname><given-names>R</given-names></name><name><surname>Brewah</surname><given-names>YA</given-names></name><name><surname>Barren</surname><given-names>P</given-names></name><name><surname>Lathigra</surname><given-names>R</given-names></name><name><surname>Langermann</surname><given-names>S</given-names></name><etal/></person-group><article-title>Identification and characterization of a novel family of pneumococcal proteins that are protective against sepsis</article-title><source>Infect Immun</source><year>2001</year><volume>69</volume><fpage>949</fpage><lpage>958</lpage><pub-id pub-id-type="pmcid">PMC97974</pub-id><pub-id pub-id-type="pmid">11159990</pub-id><pub-id pub-id-type="doi">10.1128/IAI.69.2.949-958.2001</pub-id></element-citation></ref><ref id="R41"><label>41</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brown</surname><given-names>JS</given-names></name><name><surname>Gilliland</surname><given-names>SM</given-names></name><name><surname>Holden</surname><given-names>DW</given-names></name></person-group><article-title>A <italic>Streptococcus pneumoniae</italic> pathogenicity island encoding an ABC transporter involved in iron uptake and virulence</article-title><source>Mol Microbiol</source><year>2001</year><volume>40</volume><fpage>572</fpage><lpage>585</lpage><pub-id pub-id-type="pmid">11359564</pub-id></element-citation></ref><ref id="R42"><label>42</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brown</surname><given-names>JS</given-names></name><name><surname>Gilliland</surname><given-names>SM</given-names></name><name><surname>Ruiz-Albert</surname><given-names>J</given-names></name><name><surname>Holden</surname><given-names>DW</given-names></name></person-group><article-title>Characterization of Pit, a <italic>Streptococcus pneumoniae</italic> iron uptake ABC transporter</article-title><source>Infect Immun</source><year>2002</year><volume>70</volume><fpage>4389</fpage><lpage>4398</lpage><pub-id pub-id-type="pmcid">PMC128127</pub-id><pub-id pub-id-type="pmid">12117949</pub-id><pub-id pub-id-type="doi">10.1128/IAI.70.8.4389-4398.2002</pub-id></element-citation></ref><ref id="R43"><label>43</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bidossi</surname><given-names>A</given-names></name><name><surname>Mulas</surname><given-names>L</given-names></name><name><surname>Decorosi</surname><given-names>F</given-names></name><name><surname>Colomba</surname><given-names>L</given-names></name><name><surname>Ricci</surname><given-names>S</given-names></name><name><surname>Pozzi</surname><given-names>G</given-names></name><name><surname>Deutscher</surname><given-names>J</given-names></name><name><surname>Viti</surname><given-names>C</given-names></name><name><surname>Oggioni</surname><given-names>MR</given-names></name></person-group><article-title>A functional genomics approach to establish the complement of carbohydrate transporters in <italic>Streptococcus pneumoniae</italic></article-title><source>PLoS One</source><year>2012</year><volume>7</volume><elocation-id>e33320</elocation-id><pub-id pub-id-type="pmcid">PMC3302838</pub-id><pub-id pub-id-type="pmid">22428019</pub-id><pub-id pub-id-type="doi">10.1371/journal.pone.0033320</pub-id></element-citation></ref><ref id="R44"><label>44</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Saxena</surname><given-names>S</given-names></name><name><surname>Khan</surname><given-names>N</given-names></name><name><surname>Dehinwal</surname><given-names>R</given-names></name><name><surname>Kumar</surname><given-names>A</given-names></name><name><surname>Sehgal</surname><given-names>D</given-names></name></person-group><article-title>Conserved surface accessible nucleoside ABC transporter component SP0845 is essential for pneumococcal virulence and confers protection <italic>in vivo</italic></article-title><source>PLoS One</source><year>2015</year><volume>10</volume><elocation-id>e0118154</elocation-id><pub-id pub-id-type="pmcid">PMC4331430</pub-id><pub-id pub-id-type="pmid">25689507</pub-id><pub-id pub-id-type="doi">10.1371/journal.pone.0118154</pub-id></element-citation></ref><ref id="R45"><label>45</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cron</surname><given-names>LE</given-names></name><name><surname>Bootsma</surname><given-names>HJ</given-names></name><name><surname>Noske</surname><given-names>N</given-names></name><name><surname>Burghout</surname><given-names>P</given-names></name><name><surname>Hammerschmidt</surname><given-names>S</given-names></name><name><surname>Hermans</surname><given-names>PWM</given-names></name></person-group><article-title>Surface-associated lipoprotein PpmA of <italic>Streptococcus pneumoniae</italic> is involved in colonization in a strain-specific manner</article-title><source>Microbiology</source><year>2009</year><volume>155</volume><fpage>2401</fpage><lpage>2410</lpage><pub-id pub-id-type="pmid">19389773</pub-id></element-citation></ref><ref id="R46"><label>46</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Orihuela</surname><given-names>CJ</given-names></name><name><surname>Mills</surname><given-names>J</given-names></name><name><surname>Robb</surname><given-names>CW</given-names></name><name><surname>Wilson</surname><given-names>CJ</given-names></name><name><surname>Watson</surname><given-names>DA</given-names></name><name><surname>Niesel</surname><given-names>DW</given-names></name></person-group><article-title><italic>Streptococcus pneumoniae</italic> PstS production is phosphate responsive and enhanced during growth in the murine peritoneal cavity</article-title><source>Infect Immun</source><year>2001</year><volume>69</volume><fpage>7565</fpage><lpage>7571</lpage><pub-id pub-id-type="pmcid">PMC98848</pub-id><pub-id pub-id-type="pmid">11705934</pub-id><pub-id pub-id-type="doi">10.1128/IAI.69.12.7565-7571.2001</pub-id></element-citation></ref><ref id="R47"><label>47</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hermans</surname><given-names>PWM</given-names></name><name><surname>Adrian P</surname><given-names>V</given-names></name><name><surname>Albert</surname><given-names>C</given-names></name><name><surname>Estevao</surname><given-names>S</given-names></name><name><surname>Hoogenboezem</surname><given-names>T</given-names></name><name><surname>Luijendijk</surname><given-names>IHT</given-names></name><name><surname>Kamphausen</surname><given-names>T</given-names></name><name><surname>Hammerschmidt</surname><given-names>S</given-names></name></person-group><article-title>The Streptococcal Lipoprotein Rotamase A (SlrA) is a functional peptidyl-prolyl isomerase involved in pneumococcal colonization</article-title><source>J Biol Chem</source><year>2006</year><volume>281</volume><fpage>968</fpage><lpage>976</lpage><pub-id pub-id-type="pmid">16260779</pub-id></element-citation></ref><ref id="R48"><label>48</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gori</surname><given-names>A</given-names></name><name><surname>Obolski</surname><given-names>U</given-names></name><name><surname>Swarthout</surname><given-names>TD</given-names></name><name><surname>Lourenpo</surname><given-names>J</given-names></name><name><surname>Weight</surname><given-names>CM</given-names></name><name><surname>Cornick</surname><given-names>J</given-names></name><name><surname>Kamng’ona</surname><given-names>A</given-names></name><name><surname>Mwalukomo</surname><given-names>TS</given-names></name><name><surname>Msefula</surname><given-names>J</given-names></name><name><surname>Brown</surname><given-names>C</given-names></name><name><surname>Maiden</surname><given-names>MC</given-names></name><etal/></person-group><article-title>The metabolic, virulence and antimicrobial resistance profiles of colonizing &lt;em&gt;Streptococcus pneumoniae&lt;/em&gt; shift after pneumococcal vaccine introduction in urban Malawi</article-title><source>medRxiv</source><year>2021</year><elocation-id>2021.07.21.21260914</elocation-id><pub-id pub-id-type="pmcid">PMC10656543</pub-id><pub-id pub-id-type="pmid">37978177</pub-id><pub-id pub-id-type="doi">10.1038/s41467-023-43160-y</pub-id></element-citation></ref><ref id="R49"><label>49</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jolley</surname><given-names>KA</given-names></name><name><surname>Maiden</surname><given-names>MCJ</given-names></name></person-group><article-title>BIGSdb: Scalable analysis of bacterial genome variation at the population level</article-title><source>BMC Bioinformatics</source><year>2010</year><volume>11</volume><fpage>595</fpage><pub-id pub-id-type="pmcid">PMC3004885</pub-id><pub-id pub-id-type="pmid">21143983</pub-id><pub-id pub-id-type="doi">10.1186/1471-2105-11-595</pub-id></element-citation></ref><ref id="R50"><label>50</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Petit</surname><given-names>CM</given-names></name><name><surname>Brown</surname><given-names>JR</given-names></name><name><surname>Ingraham</surname><given-names>K</given-names></name><name><surname>Bryant</surname><given-names>AP</given-names></name><name><surname>Holmes</surname><given-names>DJ</given-names></name></person-group><article-title>Lipid modification of prelipoproteins is dispensable for growth <italic>in vitro</italic> but essential for virulence in <italic>Streptococcus pneumoniae</italic></article-title><source>FEMS Microbiol Lett</source><year>2001</year><volume>200</volume><fpage>229</fpage><lpage>233</lpage><pub-id pub-id-type="pmid">11425480</pub-id></element-citation></ref><ref id="R51"><label>51</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Joyce</surname><given-names>EA</given-names></name><name><surname>Popper</surname><given-names>SJ</given-names></name><name><surname>Falkow</surname><given-names>S</given-names></name></person-group><article-title><italic>Streptococcus pneumoniae</italic> nasopharyngeal colonization induces type I interferons and interferon-induced gene expression</article-title><source>BMC Genomics</source><year>2009</year><volume>10</volume><fpage>404</fpage><pub-id pub-id-type="pmcid">PMC2743716</pub-id><pub-id pub-id-type="pmid">19712482</pub-id><pub-id pub-id-type="doi">10.1186/1471-2164-10-404</pub-id></element-citation></ref><ref id="R52"><label>52</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Skovbjerg</surname><given-names>S</given-names></name><name><surname>Norden</surname><given-names>R</given-names></name><name><surname>Martner</surname><given-names>A</given-names></name><name><surname>Samuelsson</surname><given-names>E</given-names></name><name><surname>Hynsjo</surname><given-names>L</given-names></name><name><surname>Wold</surname><given-names>AE</given-names></name></person-group><article-title>Intact pneumococci trigger transcription of interferon-related genes in human moncytes, while fragmented, autolyzed bacteria subvert this response</article-title><source>Infect Immun</source><year>2017</year><volume>85</volume><fpage>e00960</fpage><lpage>16</lpage><pub-id pub-id-type="pmcid">PMC5400851</pub-id><pub-id pub-id-type="pmid">28223347</pub-id><pub-id pub-id-type="doi">10.1128/IAI.00960-16</pub-id></element-citation></ref><ref id="R53"><label>53</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Parker</surname><given-names>D</given-names></name><name><surname>Martin</surname><given-names>FJ</given-names></name><name><surname>Soong</surname><given-names>G</given-names></name><name><surname>Harfenist</surname><given-names>BS</given-names></name><name><surname>Aguilar</surname><given-names>JL</given-names></name><name><surname>Ratner</surname><given-names>AJ</given-names></name><name><surname>Fitzgerald</surname><given-names>KA</given-names></name><name><surname>Schindler</surname><given-names>C</given-names></name><name><surname>Prince</surname><given-names>A</given-names></name></person-group><article-title><italic>Streptococcus pneumoniae</italic> DNA initiates type I interferon signaling in the respiratory tract</article-title><source>MBio</source><year>2011</year><volume>2</volume><fpage>e00016</fpage><lpage>11</lpage><pub-id pub-id-type="pmcid">PMC3101776</pub-id><pub-id pub-id-type="pmid">21586648</pub-id><pub-id pub-id-type="doi">10.1128/mBio.00016-11</pub-id></element-citation></ref><ref id="R54"><label>54</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>D’Mello</surname><given-names>A</given-names></name><name><surname>Riegler</surname><given-names>AN</given-names></name><name><surname>Martinez</surname><given-names>E</given-names></name><name><surname>Beno</surname><given-names>SM</given-names></name><name><surname>Ricketts</surname><given-names>TD</given-names></name><name><surname>Foxman</surname><given-names>EF</given-names></name><name><surname>Orihuela</surname><given-names>CJ</given-names></name><name><surname>Tettelin</surname><given-names>H</given-names></name></person-group><article-title>An in vivo atlas of host-pathogen transcriptomes during <italic>Streptococcus pneumoniae</italic> colonization and disease</article-title><source>Proc Natl Acad Sci U S A</source><year>2020</year><volume>117</volume><fpage>33507</fpage><lpage>33518</lpage><pub-id pub-id-type="pmcid">PMC7777036</pub-id><pub-id pub-id-type="pmid">33318198</pub-id><pub-id pub-id-type="doi">10.1073/pnas.2010428117</pub-id></element-citation></ref><ref id="R55"><label>55</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Koppe</surname><given-names>U</given-names></name><name><surname>Hogner</surname><given-names>K</given-names></name><name><surname>Doehn</surname><given-names>J-M</given-names></name><name><surname>Muller</surname><given-names>HC</given-names></name><name><surname>Witzenrath</surname><given-names>M</given-names></name><name><surname>Gutbier</surname><given-names>B</given-names></name><name><surname>Bauer</surname><given-names>S</given-names></name><name><surname>Pribyl</surname><given-names>T</given-names></name><name><surname>Hammerschmidt</surname><given-names>S</given-names></name><name><surname>Lohmeyer</surname><given-names>J</given-names></name><name><surname>Suttorp</surname><given-names>N</given-names></name><etal/></person-group><article-title><italic>Streptococcus pneumoniae</italic> stimulate a STING- and IFN regulatory factor 3-dependent type I IFN production in macrophages, which regulates RANTES production in macrophages, cocultured alveolar epithelial cells, and mouse lungs</article-title><source>J Immunol</source><year>2012</year><volume>188</volume><fpage>811</fpage><lpage>817</lpage><pub-id pub-id-type="pmid">22156592</pub-id></element-citation></ref><ref id="R56"><label>56</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ruiz-Moreno</surname><given-names>JS</given-names></name><name><surname>Hamann</surname><given-names>L</given-names></name><name><surname>Jin</surname><given-names>L</given-names></name><name><surname>Sander</surname><given-names>LE</given-names></name><name><surname>Puzianowska-Kuznicka</surname><given-names>M</given-names></name><name><surname>Cambier</surname><given-names>J</given-names></name><name><surname>Witzenrath</surname><given-names>M</given-names></name><name><surname>Schumann</surname><given-names>RR</given-names></name><name><surname>Suttorp</surname><given-names>N</given-names></name><name><surname>Opitz</surname><given-names>B</given-names></name><name><surname>Group</surname><given-names>CS</given-names></name></person-group><article-title>The cGAS/STING pathway detects <italic>Streptococcus pneumoniae</italic> but appears dispensable for antipneumococcal defense in mice and humans</article-title><source>Infect Immun</source><year>2018</year><volume>86</volume><fpage>e00849</fpage><lpage>17</lpage><pub-id pub-id-type="pmcid">PMC5820968</pub-id><pub-id pub-id-type="pmid">29263110</pub-id><pub-id pub-id-type="doi">10.1128/IAI.00849-17</pub-id></element-citation></ref><ref id="R57"><label>57</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>LeMessurier</surname><given-names>KS</given-names></name><name><surname>Hacker</surname><given-names>H</given-names></name><name><surname>Chi</surname><given-names>L</given-names></name><name><surname>Tuomanen</surname><given-names>E</given-names></name><name><surname>Redecke</surname><given-names>V</given-names></name></person-group><article-title>Type I interferon protects against pneumococcal invasive disease by inhibiting bacterial transmigration across the lung</article-title><source>PLoS Pathog</source><year>2013</year><volume>9</volume><elocation-id>e1003727</elocation-id><pub-id pub-id-type="pmcid">PMC3820719</pub-id><pub-id pub-id-type="pmid">24244159</pub-id><pub-id pub-id-type="doi">10.1371/journal.ppat.1003727</pub-id></element-citation></ref><ref id="R58"><label>58</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zangari</surname><given-names>T</given-names></name><name><surname>Ortigoza</surname><given-names>MB</given-names></name><name><surname>Lokken-Toyli</surname><given-names>KL</given-names></name><name><surname>Weiser</surname><given-names>JN</given-names></name></person-group><article-title>Type I interferon signaling is a common factor driving <italic>Streptococcus pneumoniae</italic> and Influenza A virus shedding and transmission</article-title><source>MBio</source><year>2021</year><volume>12</volume><fpage>e03589</fpage><lpage>20</lpage><pub-id pub-id-type="pmcid">PMC8545127</pub-id><pub-id pub-id-type="pmid">33593970</pub-id><pub-id pub-id-type="doi">10.1128/mBio.03589-20</pub-id></element-citation></ref><ref id="R59"><label>59</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Anderton</surname><given-names>JM</given-names></name><name><surname>Rajam</surname><given-names>G</given-names></name><name><surname>Romero-Steiner</surname><given-names>S</given-names></name><name><surname>Summer</surname><given-names>S</given-names></name><name><surname>Kowalczyk</surname><given-names>AP</given-names></name><name><surname>Carlone</surname><given-names>GM</given-names></name><name><surname>Sampson</surname><given-names>JS</given-names></name><name><surname>Ades</surname><given-names>EW</given-names></name></person-group><article-title>E-cadherin is a receptor for the common protein pneumococcal surface adhesin A (PsaA) of Streptococcus pneumoniae</article-title><source>Microb Pathog</source><year>2007</year><volume>42</volume><fpage>225</fpage><lpage>236</lpage><pub-id pub-id-type="pmid">17412553</pub-id></element-citation></ref><ref id="R60"><label>60</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Abdullah</surname><given-names>MR</given-names></name><name><surname>Gutierrez-Fernandez</surname><given-names>J</given-names></name><name><surname>Pribyl</surname><given-names>T</given-names></name><name><surname>Gisch</surname><given-names>N</given-names></name><name><surname>Saleh</surname><given-names>M</given-names></name><name><surname>Rohde</surname><given-names>M</given-names></name><name><surname>Petruschka</surname><given-names>L</given-names></name><name><surname>Burchhardt</surname><given-names>G</given-names></name><name><surname>Schwudke</surname><given-names>D</given-names></name><name><surname>Hermoso</surname><given-names>JA</given-names></name><name><surname>Hammerschmidt</surname><given-names>S</given-names></name></person-group><article-title>Structure of the pneumococcal L,D-carboxypeptidase DacB and pathophysiological effects of disabled cell wall hydrolases DacA and DacB</article-title><source>Mol Microbiol</source><year>2014</year><volume>93</volume><fpage>1183</fpage><lpage>1206</lpage><pub-id pub-id-type="pmid">25060741</pub-id></element-citation></ref><ref id="R61"><label>61</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Smithers</surname><given-names>L</given-names></name><name><surname>Olatunji</surname><given-names>S</given-names></name><name><surname>Caffrey</surname><given-names>M</given-names></name></person-group><article-title>Bacterial Lipoprotein Posttranslational Modifications</article-title><source>New Insights and Opportunities for Antibiotic and Vaccine Development. Front Microbiol</source><year>2021</year><volume>12</volume><elocation-id>788445</elocation-id><pub-id pub-id-type="pmcid">PMC8689077</pub-id><pub-id pub-id-type="pmid">34950121</pub-id><pub-id pub-id-type="doi">10.3389/fmicb.2021.788445</pub-id></element-citation></ref><ref id="R62"><label>62</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nguyen</surname><given-names>MT</given-names></name><name><surname>Matsuo</surname><given-names>M</given-names></name><name><surname>Niemann</surname><given-names>S</given-names></name><name><surname>Herrmann</surname><given-names>M</given-names></name><name><surname>Gotz</surname><given-names>F</given-names></name></person-group><article-title>Lipoproteins in Gram-Positive Bacteria: Abundance, Function, Fitness</article-title><source>Front Microbiol</source><year>2020</year><volume>11</volume><elocation-id>582582</elocation-id><pub-id pub-id-type="pmcid">PMC7530257</pub-id><pub-id pub-id-type="pmid">33042100</pub-id><pub-id pub-id-type="doi">10.3389/fmicb.2020.582582</pub-id></element-citation></ref><ref id="R63"><label>63</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhu</surname><given-names>L</given-names></name><name><surname>Lau</surname><given-names>GW</given-names></name></person-group><article-title>Inhibition of competence development, horizontal gene transfer and virulence in Streptococcus pneumoniae by a modified competence stimulating peptide</article-title><source>PLoS Pathog</source><year>2011</year><volume>7</volume><elocation-id>e1002241</elocation-id><pub-id pub-id-type="pmcid">PMC3164649</pub-id><pub-id pub-id-type="pmid">21909280</pub-id><pub-id pub-id-type="doi">10.1371/journal.ppat.1002241</pub-id></element-citation></ref><ref id="R64"><label>64</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Keller</surname><given-names>LE</given-names></name><name><surname>Robinson</surname><given-names>DA</given-names></name><name><surname>McDaniel</surname><given-names>LS</given-names></name></person-group><article-title>Nonencapsulated <italic>Streptococcus pneumoniae:</italic> Emergence and pathogenesis</article-title><source>MBio</source><year>2016</year><volume>7</volume><fpage>e01792</fpage><lpage>15</lpage><pub-id pub-id-type="pmcid">PMC4807366</pub-id><pub-id pub-id-type="pmid">27006456</pub-id><pub-id pub-id-type="doi">10.1128/mBio.01792-15</pub-id></element-citation></ref><ref id="R65"><label>65</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Grant</surname><given-names>CE</given-names></name><name><surname>Bailey</surname><given-names>TL</given-names></name><name><surname>Noble</surname><given-names>WS</given-names></name></person-group><article-title>FIMO: scanning for occurrences of a given motif</article-title><source>Bioinformatics</source><year>2011</year><volume>27</volume><fpage>1017</fpage><lpage>1018</lpage><pub-id pub-id-type="pmcid">PMC3065696</pub-id><pub-id pub-id-type="pmid">21330290</pub-id><pub-id pub-id-type="doi">10.1093/bioinformatics/btr064</pub-id></element-citation></ref><ref id="R66"><label>66</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Teufel</surname><given-names>F</given-names></name><name><surname>Almagro Armenteros</surname><given-names>JJ</given-names></name><name><surname>Johansen</surname><given-names>AR</given-names></name><name><surname>Gislason</surname><given-names>MH</given-names></name><name><surname>Pihl</surname><given-names>SI</given-names></name><name><surname>Tsirigos</surname><given-names>KD</given-names></name><name><surname>Winther</surname><given-names>O</given-names></name><name><surname>Brunak</surname><given-names>S</given-names></name><name><surname>von Heijne</surname><given-names>G</given-names></name><name><surname>Nielsen</surname><given-names>H</given-names></name></person-group><article-title>SignalP 6.0 predicts all five types of signal peptides using protein language models</article-title><source>Nat Biotechnol</source><year>2022</year><volume>40</volume><fpage>1023</fpage><lpage>1025</lpage><pub-id pub-id-type="pmcid">PMC9287161</pub-id><pub-id pub-id-type="pmid">34980915</pub-id><pub-id pub-id-type="doi">10.1038/s41587-021-01156-3</pub-id></element-citation></ref><ref id="R67"><label>67</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Altschul</surname><given-names>SF</given-names></name><name><surname>Madden</surname><given-names>TL</given-names></name><name><surname>Schaffer</surname><given-names>AA</given-names></name><name><surname>Zhang</surname><given-names>J</given-names></name><name><surname>Zhang</surname><given-names>Z</given-names></name><name><surname>Miller</surname><given-names>W</given-names></name><name><surname>Lipman</surname><given-names>DJ</given-names></name></person-group><article-title>Gapped BLAST and PSI-BLAST: a new generation of protein database search programs</article-title><source>Nucleic Acids Res</source><year>1997</year><volume>25</volume><fpage>3389</fpage><lpage>3402</lpage><pub-id pub-id-type="pmcid">PMC146917</pub-id><pub-id pub-id-type="pmid">9254694</pub-id><pub-id pub-id-type="doi">10.1093/nar/25.17.3389</pub-id></element-citation></ref><ref id="R68"><label>68</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sayers</surname><given-names>EW</given-names></name><name><surname>Barrett</surname><given-names>T</given-names></name><name><surname>Benson</surname><given-names>DA</given-names></name><name><surname>Bryant</surname><given-names>SH</given-names></name><name><surname>Canese</surname><given-names>K</given-names></name><name><surname>Chetvernin</surname><given-names>V</given-names></name><name><surname>Church</surname><given-names>DM</given-names></name><name><surname>Dicuccio</surname><given-names>M</given-names></name><name><surname>Edgar</surname><given-names>R</given-names></name><name><surname>Federhen</surname><given-names>S</given-names></name><name><surname>Feolo</surname><given-names>M</given-names></name><etal/></person-group><article-title>Database resources of the National Center for Biotechnology Information</article-title><source>Nucleic Acids Res</source><year>2009</year><volume>37</volume><fpage>5</fpage><lpage>15</lpage><pub-id pub-id-type="pmcid">PMC2686545</pub-id><pub-id pub-id-type="pmid">18940862</pub-id><pub-id pub-id-type="doi">10.1093/nar/gkn741</pub-id></element-citation></ref><ref id="R69"><label>69</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Letunic</surname><given-names>I</given-names></name><name><surname>Bork</surname><given-names>P</given-names></name></person-group><article-title>Interactive tree of life (iTOL) v5: An online tool for phylogenetic tree display and annotation</article-title><source>Nucleic Acids Res</source><year>2021</year><volume>49</volume><fpage>W293</fpage><lpage>W296</lpage><pub-id pub-id-type="pmcid">PMC8265157</pub-id><pub-id pub-id-type="pmid">33885785</pub-id><pub-id pub-id-type="doi">10.1093/nar/gkab301</pub-id></element-citation></ref><ref id="R70"><label>70</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Machler-Bauer</surname><given-names>A</given-names></name><name><surname>Bo</surname><given-names>Y</given-names></name><name><surname>Han</surname><given-names>L</given-names></name><name><surname>He</surname><given-names>J</given-names></name><name><surname>Lanczycki</surname><given-names>C</given-names></name><name><surname>Lu</surname><given-names>S</given-names></name><name><surname>Chitsaz</surname><given-names>F</given-names></name><name><surname>Derbyshire</surname><given-names>M</given-names></name><name><surname>Geer</surname><given-names>R</given-names></name><name><surname>Gonzales</surname><given-names>N</given-names></name><name><surname>Gwadz</surname><given-names>M</given-names></name><etal/></person-group><article-title>CDD/SPARCLE: functional classification of proteins via subfamily domain architectures</article-title><source>Nucleic Acids Res</source><year>2017</year><volume>45</volume><fpage>D200</fpage><lpage>D203</lpage><pub-id pub-id-type="pmcid">PMC5210587</pub-id><pub-id pub-id-type="pmid">27899674</pub-id><pub-id pub-id-type="doi">10.1093/nar/gkw1129</pub-id></element-citation></ref><ref id="R71"><label>71</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wick</surname><given-names>RR</given-names></name><name><surname>Judd</surname><given-names>LM</given-names></name><name><surname>Gorrie</surname><given-names>CL</given-names></name><name><surname>Holt</surname><given-names>KE</given-names></name></person-group><article-title>Unicycler: Resolving bacterial genome assemblies from short and long sequencing reads</article-title><source>PLOS Comput Biol</source><year>2017</year><volume>13</volume><elocation-id>e1005595</elocation-id><pub-id pub-id-type="pmcid">PMC5481147</pub-id><pub-id pub-id-type="pmid">28594827</pub-id><pub-id pub-id-type="doi">10.1371/journal.pcbi.1005595</pub-id></element-citation></ref><ref id="R72"><label>72</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gurevich</surname><given-names>A</given-names></name><name><surname>Saveliev</surname><given-names>V</given-names></name><name><surname>Vyahhi</surname><given-names>N</given-names></name><name><surname>Tesler</surname><given-names>G</given-names></name></person-group><article-title>QUAST: quality assessment tool for genome assemblies</article-title><source>Bioinformatics</source><year>2013</year><volume>29</volume><fpage>1072</fpage><lpage>1075</lpage><pub-id pub-id-type="pmcid">PMC3624806</pub-id><pub-id pub-id-type="pmid">23422339</pub-id><pub-id pub-id-type="doi">10.1093/bioinformatics/btt086</pub-id></element-citation></ref><ref id="R73"><label>73</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Betts</surname><given-names>M</given-names></name><name><surname>Jarvis</surname><given-names>S</given-names></name><name><surname>Jeffries</surname><given-names>A</given-names></name><name><surname>Gori</surname><given-names>A</given-names></name><name><surname>Chaguza</surname><given-names>C</given-names></name><name><surname>Msefula</surname><given-names>J</given-names></name><name><surname>Weight</surname><given-names>CM</given-names></name><name><surname>Kwambana-Adams</surname><given-names>B</given-names></name><name><surname>French</surname><given-names>N</given-names></name><name><surname>Swarthout</surname><given-names>TD</given-names></name><name><surname>Brown</surname><given-names>JS</given-names></name><etal/></person-group><article-title>Complete Genome Sequence of Streptococcus pneumoniae Strain BVJ1JL, a Serotype 1 Carriage Isolate from Malawi</article-title><source>Microbiol Resour Announc</source><year>2021</year><volume>10</volume><pub-id pub-id-type="pmcid">PMC8483660</pub-id><pub-id pub-id-type="pmid">34591678</pub-id><pub-id pub-id-type="doi">10.1128/MRA.00715-21</pub-id></element-citation></ref><ref id="R74"><label>74</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schwengers</surname><given-names>O</given-names></name><name><surname>Jelonek</surname><given-names>L</given-names></name><name><surname>Dieckmann</surname><given-names>MA</given-names></name><name><surname>Beyvers</surname><given-names>S</given-names></name><name><surname>Blom</surname><given-names>J</given-names></name><name><surname>Goesmann</surname><given-names>A</given-names></name></person-group><article-title>Bakta: Rapid and standardized annotation of bacterial genomes via alignment-free sequence identification</article-title><source>Microb Genomics</source><year>2021</year><volume>7</volume><elocation-id>000685</elocation-id><pub-id pub-id-type="pmcid">PMC8743544</pub-id><pub-id pub-id-type="pmid">34739369</pub-id><pub-id pub-id-type="doi">10.1099/mgen.0.000685</pub-id></element-citation></ref><ref id="R75"><label>75</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lachmandas</surname><given-names>E</given-names></name><name><surname>Boutens</surname><given-names>L</given-names></name><name><surname>Ratter</surname><given-names>JM</given-names></name><name><surname>Hijmans</surname><given-names>A</given-names></name><name><surname>Hooiveld</surname><given-names>GJ</given-names></name><name><surname>Joosten</surname><given-names>LAB</given-names></name><name><surname>Rodenburg</surname><given-names>RJ</given-names></name><name><surname>Fransen</surname><given-names>JAM</given-names></name><name><surname>Houtkooper</surname><given-names>RH</given-names></name><name><surname>van Crevel</surname><given-names>R</given-names></name><name><surname>Netea</surname><given-names>MG</given-names></name><etal/></person-group><article-title>Microbial stimulation of different Toll-like receptor signalling pathways induces diverse metabolic programmes in human monocytes</article-title><source>Nat Microbiol</source><year>2016</year><volume>2</volume><elocation-id>16246</elocation-id><pub-id pub-id-type="pmid">27991883</pub-id></element-citation></ref><ref id="R76"><label>76</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Eriksson</surname><given-names>M</given-names></name><name><surname>Pena-Martinez</surname><given-names>P</given-names></name><name><surname>Ramakrishnan</surname><given-names>R</given-names></name><name><surname>Chapellier</surname><given-names>M</given-names></name><name><surname>Hogberg</surname><given-names>C</given-names></name><name><surname>Glowacki</surname><given-names>G</given-names></name><name><surname>Orsmark-Pietras</surname><given-names>C</given-names></name><name><surname>Velasco-Hernandez</surname><given-names>T</given-names></name><name><surname>Lazarevic</surname><given-names>VL</given-names></name><name><surname>Juliusson</surname><given-names>G</given-names></name><name><surname>Cammenga</surname><given-names>J</given-names></name><etal/></person-group><article-title>Agonistic targeting of TLR1/TLR2 induces p38 MAPK-dependent apoptosis and NFKB-dependent differentiation of AML cells</article-title><source>Blood Adv</source><year>2017</year><volume>1</volume><fpage>2046</fpage><lpage>2057</lpage><pub-id pub-id-type="pmcid">PMC5728277</pub-id><pub-id pub-id-type="pmid">29296851</pub-id><pub-id pub-id-type="doi">10.1182/bloodadvances.2017006148</pub-id></element-citation></ref><ref id="R77"><label>77</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tettelin</surname><given-names>H</given-names></name><name><surname>Masignani</surname><given-names>V</given-names></name><name><surname>Cieslewicz</surname><given-names>MJ</given-names></name><name><surname>Donati</surname><given-names>C</given-names></name><name><surname>Medini</surname><given-names>D</given-names></name><name><surname>Ward</surname><given-names>NL</given-names></name><name><surname>Angiuoli S</surname><given-names>V</given-names></name><name><surname>Crabtree</surname><given-names>J</given-names></name><name><surname>Jones</surname><given-names>AL</given-names></name><name><surname>Durkin</surname><given-names>AS</given-names></name><name><surname>Deboy</surname><given-names>RT</given-names></name><etal/></person-group><article-title>Genome analysis of multiple pathogenic isolates of <italic>Streptococcus agalactiae:</italic> Implications for the microbial “pangenome.”</article-title><source>Proc Natl Acad Sci U S A</source><year>2005</year><volume>102</volume><fpage>13950</fpage><lpage>13955</lpage><pub-id pub-id-type="pmcid">PMC1216834</pub-id><pub-id pub-id-type="pmid">16172379</pub-id><pub-id pub-id-type="doi">10.1073/pnas.0506758102</pub-id></element-citation></ref><ref id="R78"><label>78</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pojar</surname><given-names>S</given-names></name><name><surname>Basset</surname><given-names>A</given-names></name><name><surname>Gritzfeld</surname><given-names>JF</given-names></name><name><surname>Nikolaou</surname><given-names>E</given-names></name><name><surname>van Selm</surname><given-names>S</given-names></name><name><surname>Eleveld</surname><given-names>MJ</given-names></name><name><surname>Gladstone</surname><given-names>RA</given-names></name><name><surname>Solorzano</surname><given-names>C</given-names></name><name><surname>Dalia</surname><given-names>AB</given-names></name><name><surname>German</surname><given-names>E</given-names></name><name><surname>Mitsi</surname><given-names>E</given-names></name><etal/></person-group><article-title>Isolate differences in colonization efficiency during experimental human pneumococcal challenge</article-title><source>medRxiv</source><year>2020</year><elocation-id>2020.04.20.20066399</elocation-id></element-citation></ref><ref id="R79"><label>79</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lanie</surname><given-names>JA</given-names></name><name><surname>Ng</surname><given-names>W-L</given-names></name><name><surname>Kazmierczak</surname><given-names>KM</given-names></name><name><surname>Andrzejewski</surname><given-names>TM</given-names></name><name><surname>Davidsen</surname><given-names>TM</given-names></name><name><surname>Wayne</surname><given-names>KJ</given-names></name><name><surname>Herve</surname><given-names>T</given-names></name><name><surname>Glass</surname><given-names>JI</given-names></name><name><surname>Winkler</surname><given-names>ME</given-names></name></person-group><article-title>Genome Sequence of Avery’s Virulent Serotype 2 Strain D39 of Streptococcus pneumoniae and Comparison with That of Unencapsulated Laboratory Strain R6</article-title><source>J Bacteriol</source><year>2007</year><volume>189</volume><fpage>38</fpage><lpage>51</lpage><pub-id pub-id-type="pmcid">PMC1797212</pub-id><pub-id pub-id-type="pmid">17041037</pub-id><pub-id pub-id-type="doi">10.1128/JB.01148-06</pub-id></element-citation></ref><ref id="R80"><label>80</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Moscoso</surname><given-names>M</given-names></name><name><surname>Garcia</surname><given-names>E</given-names></name><name><surname>Lopez</surname><given-names>R</given-names></name></person-group><article-title>Biofilm formation by Streptococcus pneumoniae: Role of choline, extracellular DNA, and capsular polysaccharide in microbial accretion</article-title><source>J Bacteriol</source><year>2006</year><volume>188</volume><fpage>7785</fpage><lpage>7795</lpage><pub-id pub-id-type="pmcid">PMC1636320</pub-id><pub-id pub-id-type="pmid">16936041</pub-id><pub-id pub-id-type="doi">10.1128/JB.00673-06</pub-id></element-citation></ref><ref id="R81"><label>81</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Granok</surname><given-names>AB</given-names></name><name><surname>Parsonage</surname><given-names>D</given-names></name><name><surname>Ross</surname><given-names>RP</given-names></name><name><surname>Caparon</surname><given-names>MG</given-names></name></person-group><article-title>The RofA binding site in Streptococcus pyogenes is utilized in multiple transcriptional pathways</article-title><source>J Bacteriol</source><year>2000</year><volume>182</volume><fpage>1529</fpage><lpage>1540</lpage><pub-id pub-id-type="pmcid">PMC94449</pub-id><pub-id pub-id-type="pmid">10692357</pub-id><pub-id pub-id-type="doi">10.1128/jb.182.6.1529-1540.2000</pub-id></element-citation></ref><ref id="R82"><label>82</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ramos</surname><given-names>I</given-names></name><name><surname>Smith</surname><given-names>G</given-names></name><name><surname>Ruf-Zamojski</surname><given-names>F</given-names></name><name><surname>Martinez-Romero</surname><given-names>C</given-names></name><name><surname>Fribourg</surname><given-names>M</given-names></name><name><surname>Carbajal</surname><given-names>EA</given-names></name><name><surname>Hartmann</surname><given-names>BM</given-names></name><name><surname>Nair</surname><given-names>VD</given-names></name><name><surname>Marjanovic</surname><given-names>N</given-names></name><name><surname>Monteagudo</surname><given-names>PL</given-names></name><name><surname>DeJesus</surname><given-names>VA</given-names></name><etal/></person-group><article-title>Innate Immune Response to Influenza Virus at Single-Cell Resolution in Human Epithelial Cells Revealed Paracrine Induction of Interferon Lambda 1</article-title><source>J Virol</source><year>2019</year><volume>93</volume><pub-id pub-id-type="pmcid">PMC6798124</pub-id><pub-id pub-id-type="pmid">31375585</pub-id><pub-id pub-id-type="doi">10.1128/JVI.00559-19</pub-id></element-citation></ref></ref-list></back><floats-group><boxed-text id="BX1" position="float" orientation="portrait"><caption><title>Importance</title></caption><p><italic>Streptococcus pneumoniae</italic> (pneumococcus) is an important mucosal pathogen, estimated to cause over 500,000 deaths annually. Nasopharyngeal colonisation is considered a necessary prerequisite for disease, yet many people are transiently and asymptomatically colonised by pneumococci without becoming unwell. It is therefore important to better understand how the colonisation process is controlled at the epithelial surface.</p><p>Controlled human infection studies revealed the presence of pneumococci within the epithelium of healthy volunteers (microinvasion). In this study, we focused on the regulation of epithelial microinvasion by pneumococcal lipoproteins. We found that pneumococcal lipoproteins induce epithelial inflammation but that differing lipoprotein repertoires do not significantly impact the magnitude of microinvasion. Our results highlight the potential importance of the post-translational modification of lipoproteins in the mediation of epithelial invasion during pneumococcal colonisation. Targeting mucosal innate immunity and epithelial microinvasion alongside the induction of an adaptive immune response may be effective in preventing pneumococcal colonisation and disease.</p></boxed-text><fig id="F1" position="float"><label>Figure 1</label><caption><title>Pneumococcal <italic>lgt</italic> mutants were less inflammatory compared to WT strains.</title><p>(A) SEAP reporter readout from HEK-Blue™ hTLR2 reporter cells treated with pneumococcal strains at MOI 10 for 16 hours. (B) Expression of a transcriptional module reflective of TLR2-mediated activity in Detroit 562 cells infected with TIGR4 and BHN418 for 3 hours. (C-F) Transcript levels of (C) <italic>CXCL10,</italic> (D) <italic>IFNB1,</italic> (E) <italic>IFNL1</italic> and (F) <italic>IFNL3,</italic> quantified via qPCR using total RNA extracted from Detroit 562 cells after 6 hours of infection with pneumococcal strains. Statistical significance was determined using multiple comparison test with Bonferroni’s correction (A), Mann-Whitney test (B), or Student’s <italic>t-</italic>test assuming equal variance (C-F). * indicates <italic>p</italic> &lt; 0.05, ** indicates <italic>p</italic> &lt; 0.01, *** indicates <italic>p</italic> &lt; 0.001, *** indicates <italic>p</italic> &lt; 0.0001.</p></caption><graphic xlink:href="EMS189900-f001"/></fig><fig id="F2" position="float"><label>Figure 2</label><caption><title>Mutation of <italic>lgt</italic> impaired epithelial microinvasion by <italic>Streptococcus pneumoniae,</italic> with greater defects for BHN418.</title><p>(A-F) NPE microinvasion by WT and <italic>lgt</italic> mutants. Graphs show CFU numbers for BHN418-derived (A-C) and TIGR4-derived strains (D-F) associated with (A,D), internalised into (B,E), or growing in proximity with Detroit 562 NPE cells 3 hours post infection. * indicates <italic>p</italic> &lt; 0.05, ** indicates <italic>p</italic> &lt; 0.01, *** indicates <italic>p</italic> &lt; 0.001.</p></caption><graphic xlink:href="EMS189900-f002"/></fig><fig id="F3" position="float"><label>Figure 3</label><caption><title>Growth of BHN418 <italic>lgt::cm</italic> compared to WT.</title><p>(A-B) Growth of BHN418-derived (A) and TIGR4-derived (B) strains in infection medium (MEM + 1% FBS) in the presence of Detroit 562 NPE cells. (C-D) Growth of BHN418-derived strains in infection medium (C) and in the rich growth medium THY (D) in the absence of cells. * indicates <italic>p</italic> &lt;0.05 by Student’s <italic>t-</italic>test.</p></caption><graphic xlink:href="EMS189900-f003"/></fig><fig id="F4" position="float"><label>Figure 4</label><caption><title>PalA is a lipoprotein present in BHN418 but not in TIGR4.</title><p>(A) Genetic context of the <italic>palA</italic> gene (black arrow), which is within a multi-gene operon that is part of a putative genetic island. ORFs with homology to previously described genes are labelled with the gene name. (B) Predicted structure of PalA, modelled using PHYRE, which shows a barrel-like structure with a possible central ligand binding pocket. (C) IGV snapshot demonstrating lack of TIGR4 sequencing reads mapping to the putative <italic>palA</italic> genetic island.</p></caption><graphic xlink:href="EMS189900-f004"/></fig><fig id="F5" position="float"><label>Figure 5</label><caption><title>PalA was not essential for NPE microinvasion, murine colonisation and progression to disease.</title><p>(A-C) NPE microinvasion by WT BHN418 and <italic>palA</italic> mutants, measured as NPE-associated bacteria (A), internalised bacteria (B) and planktonic bacteria growing in proximity with Detroit 562 NPE cells 3 hours post infection. (D-E) Growth of WT BHN418, the <italic>palA</italic> knock out and complementation mutants in THY (D) and infection medium (E). (F-I) Recovery of pneumococci from mice intranasally inoculated with WT BHN418 and <italic>palA::kan</italic> mutant, recovered from nasal washes when inoculated singly (F) or competitively in a 1:1 ratio (G), as well as from the lungs (H) and bloodstream (I) when tested on a pneumonia model. * indicates <italic>p</italic> &lt; 0.05.</p></caption><graphic xlink:href="EMS189900-f005"/></fig><fig id="F6" position="float"><label>Figure 6</label><caption><title>Heterologous expression of <italic>palA</italic> in P1121 (serotype 23F) did not increase epithelial microinvasion or TLR2 signalling.</title><p>(A-C) NPE microinvasion by WT P1121 and <italic>palA</italic> expression mutants, measured as NPE-associated bacteria (A), internalised bacteria (B) and planktonic bacteria growing in proximity with Detroit 562 NPE cells 3 hours post infection. (D) SEAP reporter readout from HEK-Blue™ hTLR2 reporter cells treated with pneumococcal strains at MOI 10 for 16 hours.</p></caption><graphic xlink:href="EMS189900-f006"/></fig><table-wrap id="T1" position="float" orientation="portrait"><label>Table 1</label><caption><title>Lipoproteins encoded by TIGR4 and BHN418, identified bioinformatically using MEME suite.</title></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" valign="top">BHN418 locus tag</th><th align="left" valign="top">TIGR4 locus tag</th><th align="left" valign="top">Gene name</th><th align="left" valign="top">Description of gene product</th><th align="left" valign="top">Reference</th></tr></thead><tbody><tr><td align="left" valign="top">RSS80_07140</td><td align="left" valign="top">SP_1500</td><td align="left" valign="top"><italic>aatB</italic></td><td align="left" valign="top">Amino acid transporter</td><td align="left" valign="top">(<xref ref-type="bibr" rid="R28">28</xref>)</td></tr><tr><td align="left" valign="top">RSS80_10715</td><td align="left" valign="top">SP_2169</td><td align="left" valign="top"><italic>adcA</italic></td><td align="left" valign="top">Adhesin competence protein A; zinc transporter</td><td align="left" valign="top">(<xref ref-type="bibr" rid="R29">29</xref>)</td></tr><tr><td align="left" valign="top">RSS80_04890</td><td align="left" valign="top">SP_1002</td><td align="left" valign="top"><italic>adcAII</italic></td><td align="left" valign="top">Adhesin competence protein AII; zinc transporter</td><td align="left" valign="top">(<xref ref-type="bibr" rid="R30">30</xref>)</td></tr><tr><td align="left" valign="top">RSS80_01875</td><td align="left" valign="top">SP_0366</td><td align="left" valign="top"><italic>aliA</italic></td><td align="left" valign="top">AmiA-like protein A; oligopeptide transporter</td><td align="left" valign="top">(<xref ref-type="bibr" rid="R31">31</xref>)</td></tr><tr><td align="left" valign="top">RSS80_07270</td><td align="left" valign="top">SP_1527</td><td align="left" valign="top"><italic>aliB</italic></td><td align="left" valign="top">AmiA-like protein B; oligopeptide transporter</td><td align="left" valign="top">(<xref ref-type="bibr" rid="R31">31</xref>)</td></tr><tr><td align="left" valign="top">RSS80_09070</td><td align="left" valign="top">SP_1891</td><td align="left" valign="top"><italic>amiA</italic></td><td align="left" valign="top">Aminopterin resistance locus protein A; oligopeptide transporter</td><td align="left" valign="top">(<xref ref-type="bibr" rid="R32">32</xref>)</td></tr><tr><td align="left" valign="top">RSS80_03115</td><td align="left" valign="top">SP_0629</td><td align="left" valign="top"><italic>dacB</italic></td><td align="left" valign="top">L,D-carboxypeptidase</td><td align="left" valign="top">(<xref ref-type="bibr" rid="R10">10</xref>)</td></tr><tr><td align="left" valign="top">RSS80_03240</td><td align="left" valign="top">SP_0659</td><td align="left" valign="top"><italic>etrx1</italic></td><td align="left" valign="top">Extracellular thioredoxin-like protein 1; thiol-disulfide oxidoreductase</td><td align="left" valign="top">(<xref ref-type="bibr" rid="R33">33</xref>)</td></tr><tr><td align="left" valign="top">RSS80_04875</td><td align="left" valign="top">SP_1000</td><td align="left" valign="top"><italic>etrx2</italic></td><td align="left" valign="top">Extracellular thioredoxin-like protein 2; thiol-disulfide oxidoreductase</td><td align="left" valign="top">(<xref ref-type="bibr" rid="R34">34</xref>)</td></tr><tr><td align="left" valign="top">RSS80_06715</td><td align="left" valign="top">SP_1394</td><td align="left" valign="top"><italic>glnH</italic></td><td align="left" valign="top">GlnH glutamine/polar amino acid ABC transporter substrate-binding protein</td><td align="left" valign="top">(<xref ref-type="bibr" rid="R35">35</xref>)</td></tr><tr><td align="left" valign="top">RSS80_00785</td><td align="left" valign="top">SP_0148</td><td align="left" valign="top"><italic>gshT</italic></td><td align="left" valign="top">Glutathione transporter</td><td align="left" valign="top">(<xref ref-type="bibr" rid="R36">36</xref>)</td></tr><tr><td align="left" valign="top">RSS80_03685</td><td align="left" valign="top">SP_0749</td><td align="left" valign="top"><italic>livJ</italic></td><td align="left" valign="top">Branched chain amino-acid transporter</td><td align="left" valign="top">(<xref ref-type="bibr" rid="R37">37</xref>)</td></tr><tr><td align="left" valign="top">RSS80_10385</td><td align="left" valign="top">SP_2108</td><td align="left" valign="top"><italic>malX</italic></td><td align="left" valign="top">Maltosaccharide transporter</td><td align="left" valign="top">(<xref ref-type="bibr" rid="R38">38</xref>)</td></tr><tr><td align="left" valign="top">RSS80_00790</td><td align="left" valign="top">SP_0149</td><td align="left" valign="top"><italic>metQ</italic></td><td align="left" valign="top">Methionine-binding lipoprotein Q</td><td align="left" valign="top">(<xref ref-type="bibr" rid="R39">39</xref>)</td></tr><tr><td align="left" valign="top">RSS80_05810</td><td align="left" valign="top">SP_1175</td><td align="left" valign="top"><italic>phtA</italic></td><td align="left" valign="top">Pneumococcal histidine triad protein A</td><td align="left" valign="top">(<xref ref-type="bibr" rid="R40">40</xref>)</td></tr><tr><td align="left" valign="top">RSS80_05040</td><td align="left" valign="top">SP_1032</td><td align="left" valign="top"><italic>piaA</italic></td><td align="left" valign="top">Pneumococcal iron acquisition protein A</td><td align="left" valign="top">(<xref ref-type="bibr" rid="R41">41</xref>)</td></tr><tr><td align="left" valign="top">RSS80_01305</td><td align="left" valign="top">SP_0243</td><td align="left" valign="top"><italic>pitA</italic></td><td align="left" valign="top">Pneumococcal iron transporter protein A</td><td align="left" valign="top">(<xref ref-type="bibr" rid="R42">42</xref>)</td></tr><tr><td align="left" valign="top">RSS80_08955</td><td align="left" valign="top">SP_1872</td><td align="left" valign="top"><italic>piuA</italic></td><td align="left" valign="top">Pneumococcal iron uptake protein A</td><td align="left" valign="top">(<xref ref-type="bibr" rid="R41">41</xref>)</td></tr><tr><td align="left" valign="top">RSS80_04120</td><td align="left" valign="top">SP_0845</td><td align="left" valign="top"><italic>pnrA</italic></td><td align="left" valign="top">Nucleoside transporter</td><td align="left" valign="top">(<xref ref-type="bibr" rid="R43">43</xref>, <xref ref-type="bibr" rid="R44">44</xref>)</td></tr><tr><td align="left" valign="top">RSS80_04795</td><td align="left" valign="top">SP_0981</td><td align="left" valign="top"><italic>ppmA</italic></td><td align="left" valign="top">Putative proteinase maturation protein A; peptidyl-prolyl cis–trans isomerase</td><td align="left" valign="top">(<xref ref-type="bibr" rid="R45">45</xref>)</td></tr><tr><td align="left" valign="top">RSS80_07850</td><td align="left" valign="top">SP_1650</td><td align="left" valign="top"><italic>psaA</italic></td><td align="left" valign="top">Pneumococcal surface adhesin A; manganese and zinc transporter</td><td align="left" valign="top">(<xref ref-type="bibr" rid="R11">11</xref>, <xref ref-type="bibr" rid="R12">12</xref>)</td></tr><tr><td align="left" valign="top">RSS80_10265</td><td align="left" valign="top">SP_2084</td><td align="left" valign="top"><italic>pstS</italic></td><td align="left" valign="top">Phosphate transport substrate binding protein</td><td align="left" valign="top">(<xref ref-type="bibr" rid="R46">46</xref>)</td></tr><tr><td align="left" valign="top">RSS80_09095</td><td align="left" valign="top">SP_1897</td><td align="left" valign="top"><italic>rafE</italic></td><td align="left" valign="top">Raffinose transporter</td><td align="left" valign="top">(<xref ref-type="bibr" rid="R24">24</xref>)</td></tr><tr><td align="left" valign="top">RSS80_03790</td><td align="left" valign="top">SP_0771</td><td align="left" valign="top"><italic>slrA</italic></td><td align="left" valign="top">Streptococcal lipoprotein rotamase A; cyclophilin-type peptidyl–prolyl cistrans isomerase</td><td align="left" valign="top">(<xref ref-type="bibr" rid="R47">47</xref>)</td></tr><tr><td align="left" valign="top">RSS80_04895<sup><xref ref-type="table-fn" rid="TFN3">§</xref></sup></td><td align="left" valign="top">SP_1003</td><td align="left" valign="top"><italic>phtB</italic></td><td align="left" valign="top">Pneumococcal histidine triad protein B</td><td align="left" valign="top">(<xref ref-type="bibr" rid="R40">40</xref>)</td></tr><tr><td align="left" valign="top">RSS80_04895<sup><xref ref-type="table-fn" rid="TFN3">§</xref></sup></td><td align="left" valign="top">SP_1174</td><td align="left" valign="top"><italic>phtD</italic></td><td align="left" valign="top">Pneumococcal histidine triad protein D</td><td align="left" valign="top">(<xref ref-type="bibr" rid="R40">40</xref>)</td></tr><tr><td align="left" valign="top">RSS80_06745</td><td align="left" valign="top">SP_1400</td><td align="left" valign="top"><italic>pstS2</italic></td><td align="left" valign="top">phosphate binding protein</td><td align="left" valign="top">-</td></tr><tr><td align="left" valign="top">RSS80_10885</td><td align="left" valign="top">SP_2197</td><td align="left" valign="top">-</td><td align="left" valign="top">ABC transporter binding protein</td><td align="left" valign="top">-</td></tr><tr><td align="left" valign="top">RSS80_00530</td><td align="left" valign="top">SP_0112</td><td align="left" valign="top">-</td><td align="left" valign="top">Amino acid binding protein</td><td align="left" valign="top">-</td></tr><tr><td align="left" valign="top">RSS80_09960</td><td align="left" valign="top">SP_2041</td><td align="left" valign="top">-</td><td align="left" valign="top">Membrane protein insertase</td><td align="left" valign="top">-</td></tr><tr><td align="left" valign="top">RSS80_04185</td><td align="left" valign="top">SP_0857<xref ref-type="table-fn" rid="TFN2">*</xref></td><td align="left" valign="top">-</td><td align="left" valign="top">ABC transporter substrate binding protein</td><td align="left" valign="top">-</td></tr><tr><td align="left" valign="top">RSS80_03070</td><td align="left" valign="top">SP_0620</td><td align="left" valign="top">-</td><td align="left" valign="top">Amino acid ABC transporter binding protein</td><td align="left" valign="top">-</td></tr><tr><td align="left" valign="top">RSS80_09570</td><td align="left" valign="top">SP_1975</td><td align="left" valign="top">-</td><td align="left" valign="top">Membrane protein insertase</td><td align="left" valign="top">-</td></tr><tr><td align="left" valign="top">RSS80_03435<xref ref-type="table-fn" rid="TFN2">*</xref></td><td align="left" valign="top">SP_0708<xref ref-type="table-fn" rid="TFN2">*</xref></td><td align="left" valign="top">-</td><td align="left" valign="top">ABC transporter substrate binding protein (truncated)</td><td align="left" valign="top">-</td></tr><tr><td align="left" valign="top"><bold>RSS80_03595</bold></td><td align="left" valign="top"><bold>Not present</bold></td><td align="left" valign="top"><bold>-</bold></td><td align="left" valign="top"><bold>Extracellular solute binding protein</bold></td><td align="left" valign="top"><bold>-</bold></td></tr><tr><td align="left" valign="top">RSS80_04430</td><td align="left" valign="top">SP_0899</td><td align="left" valign="top">-</td><td align="left" valign="top">Hypothetical protein</td><td align="left" valign="top">-</td></tr><tr><td align="left" valign="top">RSS80_05800<xref ref-type="table-fn" rid="TFN2">*</xref></td><td align="left" valign="top">Not assigned</td><td align="left" valign="top">-</td><td align="left" valign="top">ABC transporter substrate binding protein (truncated)</td><td align="left" valign="top">-</td></tr><tr><td align="left" valign="top">RSS80_08015</td><td align="left" valign="top">SP_1683</td><td align="left" valign="top">-</td><td align="left" valign="top">ABC transporter sugar binding protein</td><td align="left" valign="top">-</td></tr><tr><td align="left" valign="top">RSS80_08055</td><td align="left" valign="top">SP_1690</td><td align="left" valign="top">-</td><td align="left" valign="top">ABC transporter sugar binding protein</td><td align="left" valign="top">-</td></tr><tr><td align="left" valign="top">RSS80_08595</td><td align="left" valign="top">SP_1796</td><td align="left" valign="top">-</td><td align="left" valign="top">Extracellular solute binding protein</td><td align="left" valign="top">-</td></tr><tr><td align="left" valign="top">RSS80_08765</td><td align="left" valign="top">SP_1826</td><td align="left" valign="top">-</td><td align="left" valign="top">ABC transporter substrate binding protein</td><td align="left" valign="top">-</td></tr><tr><td align="left" valign="top">RSS80_00445</td><td align="left" valign="top">SP_0092</td><td align="left" valign="top">-</td><td align="left" valign="top">ABC transporter substrate binding protein</td><td align="left" valign="top">-</td></tr><tr><td align="left" valign="top">RSS80_01055</td><td align="left" valign="top">SP_0191</td><td align="left" valign="top">-</td><td align="left" valign="top">Hypothetical protein</td><td align="left" valign="top">-</td></tr><tr><td align="left" valign="top">RSS80_01080</td><td align="left" valign="top">SP_0198</td><td align="left" valign="top">-</td><td align="left" valign="top">ABC transporter substrate binding protein</td><td align="left" valign="top">-</td></tr></tbody></table><table-wrap-foot><fn id="TFN1"><p id="P45"><bold>[bold]</bold> ORF present in BHN418 but not TIGR4.</p></fn><fn id="TFN2"><label>*</label><p id="P46">Annotated as pseudogene, contained premature stop codon, or interrupted by insertion sequence</p></fn><fn id="TFN3"><label>§</label><p id="P47">RSS80_04895 was the best match BLAST result for more than one TIGR4 CDS</p><p id="P48">Not assigned: Homologous sequence present in genome but not annotated as ORF/CDS</p><p id="P49">Not present: Homologous sequence absent in genome.</p><p id="P50">TIGR locus tag and gene name are based on TIGR4 genome annotation (Genbank accession number AE005672.3).</p></fn></table-wrap-foot></table-wrap><table-wrap id="T2" position="float" orientation="portrait"><label>Table 2</label><caption><title>Presence of <italic>palA</italic> in whole genome sequences of pneumococcal isolates on the BIGSdb database, stratified by site of isolation (“source”).</title></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" valign="top">Category</th><th align="left" valign="top">Source (BIGSdb label)</th><th align="left" valign="top">Proportion (%)</th></tr></thead><tbody><tr><td align="left" valign="top">Carriage</td><td align="left" valign="top">“nasopharynx”, “pharynx”, “sputum”</td><td align="left" valign="top">14.57 (3114/21369)</td></tr><tr><td align="left" valign="top">Otitis</td><td align="left" valign="top">“ear swab”, “middle ear fluid”</td><td align="left" valign="top">13.72 (129/940)</td></tr><tr><td align="left" valign="top">Pneumonia</td><td align="left" valign="top">“lung aspirate”, “sinus aspirate”, “bronchoalveolar lavage”, “bronchi”</td><td align="left" valign="top">8.96 (25/279)</td></tr><tr><td align="left" valign="top">Invasive</td><td align="left" valign="top">“blood”, “cerebrospinal fluid”, “joint fluid”, “pleural fluid</td><td align="left" valign="top">6.54 (1837/28075)</td></tr><tr><td align="left" valign="top">Eye/pus/others</td><td align="left" valign="top">“eye swab”, “pus”, “other”</td><td align="left" valign="top">2.65 (19/716)</td></tr><tr><td align="left" valign="top">Overall</td><td align="left" valign="top"/><td align="left" valign="top">9.97 (5124/51379)</td></tr></tbody></table></table-wrap><table-wrap id="T3" position="float" orientation="portrait"><label>Table 3</label><caption><title>Bacterial strains and plasmids used in this study.</title></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" valign="top">Designation</th><th align="left" valign="top">Genotype/ Description</th><th align="left" valign="top">Source</th></tr></thead><tbody><tr><td align="left" valign="top"><underline>Strains</underline></td><td align="left" valign="top"/><td align="left" valign="top"/></tr><tr><td align="left" valign="top">TIGR4</td><td align="left" valign="top">WT Serotype 4 isolate</td><td align="left" valign="top">(<xref ref-type="bibr" rid="R26">26</xref>)</td></tr><tr><td align="left" valign="top">BHN418</td><td align="left" valign="top">WT Serotype 6B isolate</td><td align="left" valign="top">(<xref ref-type="bibr" rid="R16">16</xref>)</td></tr><tr><td align="left" valign="top">P1121</td><td align="left" valign="top">WT Serotype 23F isolate</td><td align="left" valign="top">(<xref ref-type="bibr" rid="R2">2</xref>)</td></tr><tr><td align="left" valign="top">ECSPN100</td><td align="left" valign="top">TIGR4 <italic>lgt::cm</italic></td><td align="left" valign="top">This work</td></tr><tr><td align="left" valign="top">ECSPN106</td><td align="left" valign="top">TIGR4 <italic>lgt::cm P<sub>IPTG</sub>-lgt-erm</italic> (TIGR4 <italic>lgt</italic> complementation)</td><td align="left" valign="top">This work</td></tr><tr><td align="left" valign="top">ECSPN200</td><td align="left" valign="top">BHN418 <italic>lgt::cm</italic></td><td align="left" valign="top">This work</td></tr><tr><td align="left" valign="top">ECSPN210</td><td align="left" valign="top">BHN418] <italic>lgt::cm P<sub>IPTG</sub>-lgt-erm</italic> (BHN418 <italic>lgt</italic> complementation)</td><td align="left" valign="top">This work</td></tr><tr><td align="left" valign="top">ECSPN211</td><td align="left" valign="top">BHN418 <italic>palA::kan</italic></td><td align="left" valign="top">This work</td></tr><tr><td align="left" valign="top">ECSPN213</td><td align="left" valign="top">BHN418 <italic>palA::kan P<sub>IPTG</sub>-palA-erm</italic> (BHN418 <italic>palA</italic> complementation)</td><td align="left" valign="top">This work</td></tr><tr><td align="left" valign="top">ECSPN400</td><td align="left" valign="top">P1121 <italic>P</italic><sub>IPTG</sub>-<italic>palA-erm</italic></td><td align="left" valign="top">This work</td></tr><tr><td align="left" valign="top">ECSPN401</td><td align="left" valign="top">P1121 <italic>P<sub>palA</sub>-palA-kan</italic></td><td align="left" valign="top">This work</td></tr><tr><td align="left" valign="top"><underline>Plasmids</underline></td><td align="left" valign="top"/><td align="left" valign="top"/></tr><tr><td align="left" valign="top">pASR103</td><td align="left" valign="top">Complementation construct with an IPTG inducible promoter and <italic>erm</italic> selectable marker</td><td align="left" valign="top">(<xref ref-type="bibr" rid="R64">64</xref>)</td></tr><tr><td align="left" valign="top">pPEPY</td><td align="left" valign="top">Complementation construct with a <italic>kan</italic> selectable marker</td><td align="left" valign="top">(<xref ref-type="bibr" rid="R64">64</xref>)</td></tr><tr><td align="left" valign="top">pEMcat</td><td align="left" valign="top">Minitransposon plasmid; source of <italic>cm<sup>R</sup></italic> cassette</td><td align="left" valign="top">(<xref ref-type="bibr" rid="R80">80</xref>)</td></tr><tr><td align="left" valign="top">pABG5</td><td align="left" valign="top">Cloning plasmid; source of <italic>kan<sup>R</sup></italic> cassette</td><td align="left" valign="top">(<xref ref-type="bibr" rid="R81">81</xref>)</td></tr><tr><td align="left" valign="top">pEC210</td><td align="left" valign="top">TIGR4 <italic>lgt</italic> coding region cloned into pASR103</td><td align="left" valign="top">This work</td></tr><tr><td align="left" valign="top">pEC211</td><td align="left" valign="top">BHN418 <italic>lgt</italic> coding region cloned into pASR103</td><td align="left" valign="top">This work</td></tr><tr><td align="left" valign="top">pEC213</td><td align="left" valign="top">BHN418 <italic>palA</italic> coding region cloned into pASR103</td><td align="left" valign="top">This work</td></tr><tr><td align="left" valign="top">pEC213</td><td align="left" valign="top">BHN418 <italic>palA</italic> promoter and coding region cloned into pPEPY</td><td align="left" valign="top">This work</td></tr></tbody></table></table-wrap></floats-group></article>